<?properties open_access?>
<?DTDIdentifier.IdentifierValue -//NLM//DTD Journal Publishing DTD v2.3 20070202//EN?>
<?DTDIdentifier.IdentifierType public?>
<?SourceDTD.DTDName journalpublishing.dtd?>
<?SourceDTD.Version 2.3?>
<?ConverterInfo.XSLTName jp2nlmx2.xsl?>
<?ConverterInfo.Version 1?>
<front>
  <journal-meta>
    <journal-id journal-id-type="nlm-ta">Front Genet</journal-id>
    <journal-id journal-id-type="iso-abbrev">Front Genet</journal-id>
    <journal-id journal-id-type="publisher-id">Front. Genet.</journal-id>
    <journal-title-group>
      <journal-title>Frontiers in Genetics</journal-title>
    </journal-title-group>
    <issn pub-type="epub">1664-8021</issn>
    <publisher>
      <publisher-name>Frontiers Media S.A.</publisher-name>
    </publisher>
  </journal-meta>
  <article-meta>
    <article-id pub-id-type="pmcid">7264384</article-id>
    <article-id pub-id-type="doi">10.3389/fgene.2020.00420</article-id>
    <article-categories>
      <subj-group subj-group-type="heading">
        <subject>Genetics</subject>
        <subj-group>
          <subject>Original Research</subject>
        </subj-group>
      </subj-group>
    </article-categories>
    <title-group>
      <article-title>OSluca: An Interactive Web Server to Evaluate Prognostic Biomarkers for Lung Cancer</article-title>
    </title-group>
    <contrib-group>
      <contrib contrib-type="author">
        <name>
          <surname>Yan</surname>
          <given-names>Zhongyi</given-names>
        </name>
        <xref ref-type="aff" rid="aff1">
          <sup>1</sup>
        </xref>
        <xref ref-type="author-notes" rid="fn002">
          <sup>†</sup>
        </xref>
        <uri xlink:type="simple" xlink:href="http://loop.frontiersin.org/people/692844/overview"/>
      </contrib>
      <contrib contrib-type="author">
        <name>
          <surname>Wang</surname>
          <given-names>Qiang</given-names>
        </name>
        <xref ref-type="aff" rid="aff1">
          <sup>1</sup>
        </xref>
        <xref ref-type="author-notes" rid="fn002">
          <sup>†</sup>
        </xref>
        <uri xlink:type="simple" xlink:href="http://loop.frontiersin.org/people/647946/overview"/>
      </contrib>
      <contrib contrib-type="author">
        <name>
          <surname>Lu</surname>
          <given-names>Zhendong</given-names>
        </name>
        <xref ref-type="aff" rid="aff1">
          <sup>1</sup>
        </xref>
        <xref ref-type="author-notes" rid="fn002">
          <sup>†</sup>
        </xref>
        <uri xlink:type="simple" xlink:href="http://loop.frontiersin.org/people/758265/overview"/>
      </contrib>
      <contrib contrib-type="author">
        <name>
          <surname>Sun</surname>
          <given-names>Xiaoxiao</given-names>
        </name>
        <xref ref-type="aff" rid="aff1">
          <sup>1</sup>
        </xref>
        <uri xlink:type="simple" xlink:href="http://loop.frontiersin.org/people/704935/overview"/>
      </contrib>
      <contrib contrib-type="author">
        <name>
          <surname>Song</surname>
          <given-names>Pengfei</given-names>
        </name>
        <xref ref-type="aff" rid="aff1">
          <sup>1</sup>
        </xref>
        <uri xlink:type="simple" xlink:href="http://loop.frontiersin.org/people/969293/overview"/>
      </contrib>
      <contrib contrib-type="author">
        <name>
          <surname>Dang</surname>
          <given-names>Yifang</given-names>
        </name>
        <xref ref-type="aff" rid="aff1">
          <sup>1</sup>
        </xref>
        <uri xlink:type="simple" xlink:href="http://loop.frontiersin.org/people/859742/overview"/>
      </contrib>
      <contrib contrib-type="author">
        <name>
          <surname>Xie</surname>
          <given-names>Longxiang</given-names>
        </name>
        <xref ref-type="aff" rid="aff1">
          <sup>1</sup>
        </xref>
        <uri xlink:type="simple" xlink:href="http://loop.frontiersin.org/people/654242/overview"/>
      </contrib>
      <contrib contrib-type="author">
        <name>
          <surname>Zhang</surname>
          <given-names>Lu</given-names>
        </name>
        <xref ref-type="aff" rid="aff1">
          <sup>1</sup>
        </xref>
        <uri xlink:type="simple" xlink:href="http://loop.frontiersin.org/people/702101/overview"/>
      </contrib>
      <contrib contrib-type="author">
        <name>
          <surname>Li</surname>
          <given-names>Yongqiang</given-names>
        </name>
        <xref ref-type="aff" rid="aff1">
          <sup>1</sup>
        </xref>
        <uri xlink:type="simple" xlink:href="http://loop.frontiersin.org/people/584021/overview"/>
      </contrib>
      <contrib contrib-type="author">
        <name>
          <surname>Zhu</surname>
          <given-names>Wan</given-names>
        </name>
        <xref ref-type="aff" rid="aff2">
          <sup>2</sup>
        </xref>
        <uri xlink:type="simple" xlink:href="http://loop.frontiersin.org/people/677026/overview"/>
      </contrib>
      <contrib contrib-type="author">
        <name>
          <surname>Xie</surname>
          <given-names>Tiantian</given-names>
        </name>
        <xref ref-type="aff" rid="aff3">
          <sup>3</sup>
        </xref>
        <uri xlink:type="simple" xlink:href="http://loop.frontiersin.org/people/704928/overview"/>
      </contrib>
      <contrib contrib-type="author">
        <name>
          <surname>Ma</surname>
          <given-names>Jing</given-names>
        </name>
        <xref ref-type="aff" rid="aff3">
          <sup>3</sup>
        </xref>
        <uri xlink:type="simple" xlink:href="http://loop.frontiersin.org/people/31618258/overview"/>
      </contrib>
      <contrib contrib-type="author">
        <name>
          <surname>Zhang</surname>
          <given-names>Yijie</given-names>
        </name>
        <xref ref-type="aff" rid="aff3">
          <sup>3</sup>
        </xref>
        <uri xlink:type="simple" xlink:href="http://loop.frontiersin.org/people/844163/overview"/>
      </contrib>
      <contrib contrib-type="author">
        <name>
          <surname>Guo</surname>
          <given-names>Xiangqian</given-names>
        </name>
        <xref ref-type="aff" rid="aff1">
          <sup>1</sup>
        </xref>
        <xref ref-type="corresp" rid="c001">
          <sup>*</sup>
        </xref>
        <uri xlink:type="simple" xlink:href="http://loop.frontiersin.org/people/605469/overview"/>
      </contrib>
    </contrib-group>
    <aff id="aff1"><sup>1</sup><institution>Department of Predictive Medicine, Institute of Biomedical Informatics, Cell Signal Transduction Laboratory, Bioinformatics Center, Henan Provincial Engineering Center for Tumor Molecular Medicine, School of Software, School of Basic Medical Sciences, Henan University</institution>, <addr-line>Kaifeng</addr-line>, <country>China</country></aff>
    <aff id="aff2"><sup>2</sup><institution>Department of Anesthesia, Stanford University</institution>, <addr-line>Stanford, CA</addr-line>, <country>United States</country></aff>
    <aff id="aff3"><sup>3</sup><institution>Department of Respiratory and Critical Care Medicine, Huaihe Hospital of Henan University</institution>, <addr-line>Kaifeng</addr-line>, <country>China</country></aff>
    <author-notes>
      <fn fn-type="edited-by">
        <p>Edited by: Harinder Singh, J. Craig Venter Institute, United States</p>
      </fn>
      <fn fn-type="edited-by">
        <p>Reviewed by: Sipeng Shen, Nanjing Medical University, China; Sudipto Saha, Bose Institute, India</p>
      </fn>
      <corresp id="c001">*Correspondence: Xiangqian Guo, <email>xqguo@henu.edu.cn</email></corresp>
      <fn fn-type="other" id="fn002">
        <p><sup>†</sup>These authors have contributed equally to this work</p>
      </fn>
      <fn fn-type="other" id="fn004">
        <p>This article was submitted to Bioinformatics and Computational Biology, a section of the journal Frontiers in Genetics</p>
      </fn>
    </author-notes>
    <pub-date pub-type="epub">
      <day>26</day>
      <month>5</month>
      <year>2020</year>
    </pub-date>
    <pub-date pub-type="collection">
      <year>2020</year>
    </pub-date>
    <volume>11</volume>
    <elocation-id>420</elocation-id>
    <history>
      <date date-type="received">
        <day>30</day>
        <month>10</month>
        <year>2019</year>
      </date>
      <date date-type="accepted">
        <day>03</day>
        <month>4</month>
        <year>2020</year>
      </date>
    </history>
    <permissions>
      <copyright-statement>Copyright © 2020 Yan, Wang, Lu, Sun, Song, Dang, Xie, Zhang, Li, Zhu, Xie, Ma, Zhang and Guo.</copyright-statement>
      <copyright-year>2020</copyright-year>
      <copyright-holder>Yan, Wang, Lu, Sun, Song, Dang, Xie, Zhang, Li, Zhu, Xie, Ma, Zhang and Guo</copyright-holder>
      <license xlink:href="http://creativecommons.org/licenses/by/4.0/">
        <license-p>This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.</license-p>
      </license>
    </permissions>
    <abstract>
      <p>Lung cancer is the principal cause of leading cancer-related incidence and mortality in the world. Various studies have excavated the potential prognostic biomarkers for cancer patients based on gene expression profiles. However, most of these reported biomarkers lack independent validation in multiple cohorts. Herein, we collected 35 datasets with long-term follow-up clinical information from TCGA (2 cohorts), GEO (32 cohorts), and Roepman study (1 cohort), and developed a web server named OSluca (Online consensus Survival for Lung Cancer) to assess the prognostic value of genes in lung cancer. The input of OSluca is an official gene symbol, and the output web page of OSluca displays the survival analysis summary with a forest plot and a survival table from Cox proportional regression in each cohort and combined cohorts. To test the performance of OSluca, 104 previously reported prognostic biomarkers in lung carcinoma were evaluated in OSluca. In conclusion, OSluca is a highly valuable and interactive prognostic web server for lung cancer. It can be accessed at <ext-link ext-link-type="uri" xlink:href="http://bioinfo.henu.edu.cn/LUCA/LUCAList.jsp">http:// bioinfo.henu.edu.cn/LUCA/LUCAList.jsp</ext-link>.</p>
    </abstract>
    <kwd-group>
      <kwd>survival</kwd>
      <kwd>lung cancer</kwd>
      <kwd>biomarker</kwd>
      <kwd>prognosis</kwd>
      <kwd>OSluca</kwd>
    </kwd-group>
    <counts>
      <fig-count count="3"/>
      <table-count count="2"/>
      <equation-count count="0"/>
      <ref-count count="62"/>
      <page-count count="10"/>
      <word-count count="0"/>
    </counts>
  </article-meta>
</front>
<body>
  <sec id="S1">
    <title>Introduction</title>
    <p>Lung cancer (LUCA) is an aggressive disease with leading mortality and incidence in the world. Based on histology, there are two types of LUCA, including non-small cell lung cancer (NSCLC), which accounts for 80% of LUCA and small cell lung cancer (SCLC), which accounts for approximately 20% of LUCA (<xref rid="B34" ref-type="bibr">Raponi et al., 2006</xref>; <xref rid="B7" ref-type="bibr">Bray et al., 2018</xref>). NSCLC can be further sub-divided into four subtypes, including adenocarcinoma, squamous cell carcinoma, large cell carcinoma, and bronchioloalveolar carcinoma (<xref rid="B33" ref-type="bibr">Ramalingam et al., 2011</xref>). Classical histological subtypes indeed play a dominant role in treatment and prognosis of lung cancer. Recently, reclassification of lung cancer based on tumor biomarkers improves lung cancer therapy (<xref rid="B3" ref-type="bibr">Beer et al., 2002</xref>; <xref rid="B17" ref-type="bibr">Hoadley et al., 2018</xref>).</p>
    <p>Many studies have demonstrated that using clinical-association-prognostic biomarkers can assist the characterization of cancer subtypes and provide new insights of cancer recurrence and patients response to more precise therapies (<xref rid="B29" ref-type="bibr">Meyerson and Carbone, 2005</xref>; <xref rid="B4" ref-type="bibr">Bild et al., 2006</xref>; <xref rid="B34" ref-type="bibr">Raponi et al., 2006</xref>). It is worth noting that numerous single- or multi-prognostic biomarkers have been identified using high-throughput profiling methods (<xref rid="B34" ref-type="bibr">Raponi et al., 2006</xref>). By mining a mass of these profiling data deposited in public database, meta-analysis has exploited potential prognostic genes, such as <italic>KRT8</italic> (<xref rid="B54" ref-type="bibr">Xie et al., 2019a</xref>). However, for biologists and clinicians, it is technically difficult to analyze these massive public data to screen and develop prognostic biomarkers. Previously, we have built several web servers of prognostic biomarker analysis for breast cancer, esophageal carcinoma, etc. (<xref rid="B48" ref-type="bibr">Wang et al., 2019a</xref>,<xref rid="B50" ref-type="bibr">b</xref>,<xref rid="B51" ref-type="bibr">c</xref>, <xref rid="B49" ref-type="bibr">2020</xref>; <xref rid="B55" ref-type="bibr">Xie et al., 2019b</xref>,<xref rid="B56" ref-type="bibr">c</xref>; <xref rid="B58" ref-type="bibr">Yan et al., 2019</xref>; <xref rid="B60" ref-type="bibr">Zhang et al., 2019</xref>, <xref rid="B59" ref-type="bibr">2020</xref>; <xref rid="B10" ref-type="bibr">Dong et al., 2020</xref>). In this current study, we have integrated bulky RNA expression profiles of lung cancer with clinical survival information, mainly from TCGA (The Cancer Genome Atlas) and GEO (the Gene Expression Omnibus) databases, and built a prognostic analysis web server named OSluca (Online consensus Survival for Lung Cancer) to analyze and evaluate prognostic potency of gene in 35 independent lung cancer cohorts.</p>
  </sec>
  <sec sec-type="materials|methods" id="S2">
    <title>Materials and Methods</title>
    <sec id="S2.SS1">
      <title>Collection of Lung Cancer Datasets</title>
      <p>The lung cancer cohorts for OSluca with expression profiling and clinical follow-up data were collected from PubMed, TCGA,<sup><xref ref-type="fn" rid="footnote1">1</xref></sup> and GEO<sup><xref ref-type="fn" rid="footnote2">2</xref></sup> by searching the keywords: “lung” AND “cancer” AND “survival” (<xref rid="T1" ref-type="table">Table 1</xref>). The dataset for each cohort that met these following criteria will be included in OSluca: (1) have RNA sequencing or gene microarray data; (2) have complete follow-up data, such as overall survival and status (<xref rid="B26" ref-type="bibr">Liu et al., 2018</xref>); (3) all the data were specific for lung cancer, not from secondary or metastatic lung tumor from other types of tumors; (4) the cohort size is no less than 30 cases. The primary clinical pathological characteristics of lung cancer patients are listed in <xref rid="T1" ref-type="table">Table 1</xref>.</p>
      <table-wrap id="T1" position="float">
        <label>TABLE 1</label>
        <caption>
          <p>Summary of clinical characteristics of lung cancer cohorts in Online Consensus Survival for Lung Cancer (OSluca).</p>
        </caption>
        <table frame="hsides" rules="groups" cellspacing="5" cellpadding="5">
          <thead>
            <tr>
              <td valign="top" align="left" rowspan="1" colspan="1"/>
              <td valign="top" align="center" colspan="5" rowspan="1">
                <bold>NSCLC</bold>
                <hr/>
              </td>
              <td valign="top" align="center" rowspan="1" colspan="1">
                <bold>SCLC (<italic>N</italic> = 223)</bold>
              </td>
              <td valign="top" align="center" rowspan="1" colspan="1">
                <bold>#NA (<italic>N</italic> = 85)</bold>
              </td>
            </tr>
            <tr>
              <td valign="top" align="justify" rowspan="1" colspan="1"/>
              <td valign="top" align="center" rowspan="1" colspan="1">
                <bold>NSCLC, Total (<italic>N</italic> = 4937)</bold>
              </td>
              <td valign="top" align="center" rowspan="1" colspan="1">
                <bold>AD (<italic>N</italic> = 3345)</bold>
              </td>
              <td valign="top" align="center" rowspan="1" colspan="1">
                <bold>SCC (<italic>N</italic> = 1381)</bold>
              </td>
              <td valign="top" align="center" rowspan="1" colspan="1">
                <bold>LCC (<italic>N</italic> = 197)</bold>
              </td>
              <td valign="top" align="center" rowspan="1" colspan="1">
                <bold>NOS (<italic>N</italic> = 194)</bold>
              </td>
              <td rowspan="1" colspan="1"/>
              <td rowspan="1" colspan="1"/>
            </tr>
          </thead>
          <tbody>
            <tr>
              <td valign="top" align="left" rowspan="1" colspan="1">Age, year</td>
              <td valign="top" align="center" rowspan="1" colspan="1">64 (13–91)</td>
              <td valign="top" align="center" rowspan="1" colspan="1">64 (13–90)</td>
              <td valign="top" align="center" rowspan="1" colspan="1">66 (39–83)</td>
              <td valign="top" align="center" rowspan="1" colspan="1">63 (39–81)</td>
              <td valign="top" align="center" rowspan="1" colspan="1">62 (22–80)</td>
              <td valign="top" align="center" rowspan="1" colspan="1">64 (40–83)</td>
              <td valign="top" align="center" rowspan="1" colspan="1">58 (15–82)</td>
            </tr>
            <tr>
              <td valign="top" align="left" rowspan="1" colspan="1">Gender</td>
              <td valign="top" align="justify" rowspan="1" colspan="1"/>
              <td rowspan="1" colspan="1"/>
              <td rowspan="1" colspan="1"/>
              <td rowspan="1" colspan="1"/>
              <td rowspan="1" colspan="1"/>
              <td rowspan="1" colspan="1"/>
              <td rowspan="1" colspan="1"/>
            </tr>
            <tr>
              <td valign="top" align="left" rowspan="1" colspan="1">Male, %</td>
              <td valign="top" align="center" rowspan="1" colspan="1">52.6</td>
              <td valign="top" align="center" rowspan="1" colspan="1">46.9</td>
              <td valign="top" align="center" rowspan="1" colspan="1">68.3</td>
              <td valign="top" align="center" rowspan="1" colspan="1">77.2</td>
              <td valign="top" align="center" rowspan="1" colspan="1">12.9</td>
              <td valign="top" align="center" rowspan="1" colspan="1">58.1</td>
              <td valign="top" align="center" rowspan="1" colspan="1">50</td>
            </tr>
            <tr>
              <td valign="top" align="left" rowspan="1" colspan="1">Female, %</td>
              <td valign="top" align="center" rowspan="1" colspan="1">38.8</td>
              <td valign="top" align="center" rowspan="1" colspan="1">47.7</td>
              <td valign="top" align="center" rowspan="1" colspan="1">23.7</td>
              <td valign="top" align="center" rowspan="1" colspan="1">18.1</td>
              <td valign="top" align="center" rowspan="1" colspan="1">12.4</td>
              <td valign="top" align="center" rowspan="1" colspan="1">41.9</td>
              <td valign="top" align="center" rowspan="1" colspan="1">50</td>
            </tr>
            <tr>
              <td valign="top" align="left" rowspan="1" colspan="1">#NA, %</td>
              <td valign="top" align="center" rowspan="1" colspan="1">8.6</td>
              <td valign="top" align="center" rowspan="1" colspan="1">5.4</td>
              <td valign="top" align="center" rowspan="1" colspan="1">8.0</td>
              <td valign="top" align="center" rowspan="1" colspan="1">4.7</td>
              <td valign="top" align="center" rowspan="1" colspan="1">73.7</td>
              <td valign="top" align="center" rowspan="1" colspan="1">0</td>
              <td valign="top" align="center" rowspan="1" colspan="1">0</td>
            </tr>
            <tr>
              <td valign="top" align="left" rowspan="1" colspan="1">Stage*</td>
              <td valign="top" align="justify" rowspan="1" colspan="1"/>
              <td rowspan="1" colspan="1"/>
              <td rowspan="1" colspan="1"/>
              <td rowspan="1" colspan="1"/>
              <td rowspan="1" colspan="1"/>
              <td rowspan="1" colspan="1"/>
              <td rowspan="1" colspan="1"/>
            </tr>
            <tr>
              <td valign="top" align="left" rowspan="1" colspan="1">I, <italic>n</italic></td>
              <td valign="top" align="center" rowspan="1" colspan="1">2301</td>
              <td valign="top" align="center" rowspan="1" colspan="1">1,653</td>
              <td valign="top" align="center" rowspan="1" colspan="1">567</td>
              <td valign="top" align="center" rowspan="1" colspan="1">66</td>
              <td valign="top" align="center" rowspan="1" colspan="1">28</td>
              <td valign="top" align="center" rowspan="1" colspan="1">10</td>
              <td valign="top" align="center" rowspan="1" colspan="1">9</td>
            </tr>
            <tr>
              <td valign="top" align="left" rowspan="1" colspan="1">II, <italic>n</italic></td>
              <td valign="top" align="center" rowspan="1" colspan="1">889</td>
              <td valign="top" align="center" rowspan="1" colspan="1">500</td>
              <td valign="top" align="center" rowspan="1" colspan="1">347</td>
              <td valign="top" align="center" rowspan="1" colspan="1">27</td>
              <td valign="top" align="center" rowspan="1" colspan="1">15</td>
              <td valign="top" align="center" rowspan="1" colspan="1">5</td>
              <td valign="top" align="center" rowspan="1" colspan="1">4</td>
            </tr>
            <tr>
              <td valign="top" align="left" rowspan="1" colspan="1">III, <italic>n</italic></td>
              <td valign="top" align="center" rowspan="1" colspan="1">595</td>
              <td valign="top" align="center" rowspan="1" colspan="1">366</td>
              <td valign="top" align="center" rowspan="1" colspan="1">199</td>
              <td valign="top" align="center" rowspan="1" colspan="1">18</td>
              <td valign="top" align="center" rowspan="1" colspan="1">12</td>
              <td valign="top" align="center" rowspan="1" colspan="1">2</td>
              <td valign="top" align="center" rowspan="1" colspan="1">3</td>
            </tr>
            <tr>
              <td valign="top" align="left" rowspan="1" colspan="1">IV, <italic>n</italic></td>
              <td valign="top" align="center" rowspan="1" colspan="1">101</td>
              <td valign="top" align="center" rowspan="1" colspan="1">73</td>
              <td valign="top" align="center" rowspan="1" colspan="1">13</td>
              <td valign="top" align="center" rowspan="1" colspan="1">2</td>
              <td valign="top" align="center" rowspan="1" colspan="1">13</td>
              <td valign="top" align="center" rowspan="1" colspan="1">0</td>
              <td valign="top" align="center" rowspan="1" colspan="1">0</td>
            </tr>
            <tr>
              <td valign="top" align="left" rowspan="1" colspan="1">T stage 1/2/3/4/#NA</td>
              <td valign="top" align="center" rowspan="1" colspan="1">646/1074/230/103/2884</td>
              <td valign="top" align="center" rowspan="1" colspan="1">468/663/102/49/2063</td>
              <td valign="top" align="center" rowspan="1" colspan="1">155/362/109/39/716</td>
              <td valign="top" align="center" rowspan="1" colspan="1">20/44/17/9/107</td>
              <td valign="top" align="center" rowspan="1" colspan="1">3/5/2/6/178</td>
              <td valign="top" align="center" rowspan="1" colspan="1">11/13/5/4/190</td>
              <td valign="top" align="center" rowspan="1" colspan="1">28/20/10/6/21</td>
            </tr>
            <tr>
              <td valign="top" align="left" rowspan="1" colspan="1">N Stage 0/1/2/3/#NA</td>
              <td valign="top" align="center" rowspan="1" colspan="1">1638/495/280/21</td>
              <td valign="top" align="center" rowspan="1" colspan="1">1038/254/198/5/1859</td>
              <td valign="top" align="center" rowspan="1" colspan="1">549/218/70/7/537</td>
              <td valign="top" align="center" rowspan="1" colspan="1">48/20/17/5/107</td>
              <td valign="top" align="center" rowspan="1" colspan="1">3/3/4/4/180</td>
              <td valign="top" align="center" rowspan="1" colspan="1">14/4/12/6/187</td>
              <td valign="top" align="center" rowspan="1" colspan="1">33/25/5/1/21</td>
            </tr>
            <tr>
              <td valign="top" align="left" rowspan="1" colspan="1">M stage 0/1/#NA</td>
              <td valign="top" align="center" rowspan="1" colspan="1">1685/42/3210</td>
              <td valign="top" align="center" rowspan="1" colspan="1">853/26/2466</td>
              <td valign="top" align="center" rowspan="1" colspan="1">740/8/633</td>
              <td valign="top" align="center" rowspan="1" colspan="1">82/2/113</td>
              <td valign="top" align="center" rowspan="1" colspan="1">10/6/178</td>
              <td valign="top" align="center" rowspan="1" colspan="1">33/4/186</td>
              <td valign="top" align="center" rowspan="1" colspan="1">63/2/20</td>
            </tr>
            <tr>
              <td valign="top" align="left" rowspan="1" colspan="1">Smoking/non-smoking/#NA</td>
              <td valign="top" align="center" rowspan="1" colspan="1">1839/262/2836</td>
              <td valign="top" align="center" rowspan="1" colspan="1">1112/256/1977</td>
              <td valign="top" align="center" rowspan="1" colspan="1">618/3/760</td>
              <td valign="top" align="center" rowspan="1" colspan="1">40/1/156</td>
              <td valign="top" align="center" rowspan="1" colspan="1">9/2/183</td>
              <td valign="top" align="center" rowspan="1" colspan="1">18/1/204</td>
              <td valign="top" align="center" rowspan="1" colspan="1">9/8/68</td>
            </tr>
            <tr>
              <td valign="top" align="left" rowspan="1" colspan="1">OS, mo</td>
              <td valign="top" align="center" rowspan="1" colspan="1">46 (0.03–256)</td>
              <td valign="top" align="center" rowspan="1" colspan="1">48 (0.03–242)</td>
              <td valign="top" align="center" rowspan="1" colspan="1">41 (0.03–256)</td>
              <td valign="top" align="center" rowspan="1" colspan="1">46 (0.1–216)</td>
              <td valign="top" align="center" rowspan="1" colspan="1">38 (0.5–208)</td>
              <td valign="top" align="center" rowspan="1" colspan="1">51 (2–211)</td>
              <td valign="top" align="center" rowspan="1" colspan="1">68 (2–244)</td>
            </tr>
            <tr>
              <td valign="top" align="left" rowspan="1" colspan="1">DSS, mo</td>
              <td valign="top" align="center" rowspan="1" colspan="1">42 (0.03–256)</td>
              <td valign="top" align="center" rowspan="1" colspan="1">43 (0.19–242)</td>
              <td valign="top" align="center" rowspan="1" colspan="1">41 (0.03–256)</td>
              <td valign="top" align="center" rowspan="1" colspan="1">45 (1–216)</td>
              <td valign="top" align="center" rowspan="1" colspan="1">36 (6–76)</td>
              <td valign="top" align="center" rowspan="1" colspan="1">24 (2–140)</td>
              <td valign="top" align="center" rowspan="1" colspan="1">69 (2–244)</td>
            </tr>
            <tr>
              <td valign="top" align="left" rowspan="1" colspan="1">DFI, mo</td>
              <td valign="top" align="center" rowspan="1" colspan="1">33 (0.16–242)</td>
              <td valign="top" align="center" rowspan="1" colspan="1">32 (0.6–242)</td>
              <td valign="top" align="center" rowspan="1" colspan="1">34 (0.16–159)</td>
              <td valign="top" align="center" rowspan="1" colspan="1">–</td>
              <td valign="top" align="center" rowspan="1" colspan="1">–</td>
              <td valign="top" align="center" rowspan="1" colspan="1">–</td>
              <td valign="top" align="center" rowspan="1" colspan="1">–</td>
            </tr>
            <tr>
              <td valign="top" align="left" rowspan="1" colspan="1">PFI, mo</td>
              <td valign="top" align="center" rowspan="1" colspan="1">33 (0.03–242)</td>
              <td valign="top" align="center" rowspan="1" colspan="1">36 (0.03–242)</td>
              <td valign="top" align="center" rowspan="1" colspan="1">30 (0.03–180)</td>
              <td valign="top" align="center" rowspan="1" colspan="1">53 (1.8–164)</td>
              <td valign="top" align="center" rowspan="1" colspan="1">4 (0.23–54)</td>
              <td valign="top" align="center" rowspan="1" colspan="1">–</td>
              <td valign="top" align="center" rowspan="1" colspan="1">30 (2–73)</td>
            </tr>
          </tbody>
        </table>
        <table-wrap-foot>
          <attrib>
            <italic>NSCLC, non-small cell lung cancer; SCLC, small cell lung cancer; AD, adenocarcinoma; SCC, squamous cell carcinoma; LCC, large cell cancer; NOS, NSCLC, not otherwise specified; F, female; M, male; n, number; mo, months; OS, overall survival; DSS, disease-specific survival; DFI, disease-free interval; PFI, progression-free interval or recurrence free survival. *The stage only counts stages of lung cancer patients described in the original datasets; #NA, data lost or unknown.</italic>
          </attrib>
        </table-wrap-foot>
      </table-wrap>
    </sec>
    <sec id="S2.SS2">
      <title>Construction of OSluca Web Server</title>
      <p>Online consensus Survival for Lung Cancer is built in a tomcat server as previously described with minor modifications (<xref rid="B50" ref-type="bibr">Wang et al., 2019b</xref>, <xref rid="B51" ref-type="bibr">c</xref>; <xref rid="B55" ref-type="bibr">Xie et al., 2019b</xref>, <xref rid="B56" ref-type="bibr">c</xref>; <xref rid="B58" ref-type="bibr">Yan et al., 2019</xref>; <xref rid="B60" ref-type="bibr">Zhang et al., 2019</xref>). Briefly, front-end application was used for inputting query and displaying the results. Java and R package were used to analyze request and output the results. In addition, profiles and clinical information were stored in the SQL Server database. The prognostic significance of inputted gene is determined by analyzing the association of gene expression and survival time using the R package “survival.” In addition, a genome-wide pre-calculation of Cox proportional regression for all the human genes were performed as well, and the home page of OSluca could display the survival analysis summary with a forest plot and a table of Cox proportional regression result for inputted gene in all cohorts with <italic>P</italic>-value and HR [(95% confidence interval (CI)] with the built-in upper 25% cutoff. The R package “forestplot” was used to produce the forest plot for inputted gene in OSluca web server.</p>
    </sec>
    <sec id="S2.SS3">
      <title>Validation of Previously Reported Prognostic Biomarkers of Lung Cancer in OSluca</title>
      <p>Keywords including “lung cancer,” “survival,” “biomarker,” and “prognosis” were used to search biomarkers of lung cancer in NCBI PubMed. We finally obtained 104 prognostic biomarkers using the following criteria (<xref rid="T2" ref-type="table">Table 2</xref>): (1) immunohistochemistry (IHC) or qRT-PCR (qPCR) detection of biomarkers in primary cancer tissue; (2) a significant association between biomarker and survival; (3) the sample size must be above 50 cases; (4) the study was published in the English for full access.</p>
      <table-wrap id="T2" position="float">
        <label>TABLE 2</label>
        <caption>
          <p>Clinico-pathological traits of lung cancer cohorts.</p>
        </caption>
        <table frame="hsides" rules="groups" cellspacing="5" cellpadding="5">
          <thead>
            <tr>
              <td valign="top" align="left" rowspan="1" colspan="1">
                <bold>Datasets</bold>
              </td>
              <td valign="top" align="center" rowspan="1" colspan="1">
                <bold>Cohorts</bold>
              </td>
              <td valign="top" align="center" rowspan="1" colspan="1">
                <bold>Platform</bold>
              </td>
              <td valign="top" align="center" rowspan="1" colspan="1">
                <bold>Histological type</bold>
              </td>
              <td valign="top" align="center" rowspan="1" colspan="1">
                <bold>Survival</bold>
              </td>
              <td valign="top" align="center" rowspan="1" colspan="1">
                <bold>Samples</bold>
              </td>
              <td valign="top" align="left" rowspan="1" colspan="1">
                <bold>References</bold>
              </td>
            </tr>
          </thead>
          <tbody>
            <tr>
              <td valign="top" align="left" rowspan="1" colspan="1">Rockville</td>
              <td valign="top" align="center" rowspan="1" colspan="1">GSE102287</td>
              <td valign="top" align="center" rowspan="1" colspan="1">GPL570</td>
              <td valign="top" align="center" rowspan="1" colspan="1">AD/SCC/NOS</td>
              <td valign="top" align="center" rowspan="1" colspan="1">OS</td>
              <td valign="top" align="center" rowspan="1" colspan="1">32</td>
              <td valign="top" align="left" rowspan="1" colspan="1">
                <xref rid="B30" ref-type="bibr">Mitchell et al., 2017</xref>
              </td>
            </tr>
            <tr>
              <td valign="top" align="left" rowspan="1" colspan="1">Heidelberg</td>
              <td valign="top" align="center" rowspan="1" colspan="1">GSE10245</td>
              <td valign="top" align="center" rowspan="1" colspan="1">GPL570</td>
              <td valign="top" align="center" rowspan="1" colspan="1">AD/SCC</td>
              <td valign="top" align="center" rowspan="1" colspan="1">OS</td>
              <td valign="top" align="center" rowspan="1" colspan="1">58</td>
              <td valign="top" align="left" rowspan="1" colspan="1">
                <xref rid="B21" ref-type="bibr">Kuner et al., 2009</xref>
              </td>
            </tr>
            <tr>
              <td valign="top" align="left" rowspan="1" colspan="1">Koto-ku</td>
              <td valign="top" align="center" rowspan="1" colspan="1">GSE1037</td>
              <td valign="top" align="center" rowspan="1" colspan="1">GPL962</td>
              <td valign="top" align="center" rowspan="1" colspan="1">AD/SCC/SCLC</td>
              <td valign="top" align="center" rowspan="1" colspan="1">OS</td>
              <td valign="top" align="center" rowspan="1" colspan="1">61</td>
              <td valign="top" align="left" rowspan="1" colspan="1">
                <xref rid="B20" ref-type="bibr">Jones et al., 2004</xref>
              </td>
            </tr>
            <tr>
              <td valign="top" align="left" rowspan="1" colspan="1">Basel</td>
              <td valign="top" align="center" rowspan="1" colspan="1">GSE11117</td>
              <td valign="top" align="center" rowspan="1" colspan="1">GPL6650</td>
              <td valign="top" align="center" rowspan="1" colspan="1">AD/SCC/NOS</td>
              <td valign="top" align="center" rowspan="1" colspan="1">OS</td>
              <td valign="top" align="center" rowspan="1" colspan="1">41</td>
              <td valign="top" align="left" rowspan="1" colspan="1">
                <xref rid="B2" ref-type="bibr">Baty et al., 2010</xref>
              </td>
            </tr>
            <tr>
              <td valign="top" align="left" rowspan="1" colspan="1">Nagoya</td>
              <td valign="top" align="center" rowspan="1" colspan="1">GSE11969</td>
              <td valign="top" align="center" rowspan="1" colspan="1">GPL7015</td>
              <td valign="top" align="center" rowspan="1" colspan="1">AD/SCC/LCC</td>
              <td valign="top" align="center" rowspan="1" colspan="1">OS</td>
              <td valign="top" align="center" rowspan="1" colspan="1">149</td>
              <td valign="top" align="left" rowspan="1" colspan="1">
                <xref rid="B42" ref-type="bibr">Takeuchi et al., 2006</xref>
              </td>
            </tr>
            <tr>
              <td valign="top" align="left" rowspan="1" colspan="1">Groningen</td>
              <td valign="top" align="center" rowspan="1" colspan="1">GSE12428</td>
              <td valign="top" align="center" rowspan="1" colspan="1">GPL1708</td>
              <td valign="top" align="center" rowspan="1" colspan="1">SCC</td>
              <td valign="top" align="center" rowspan="1" colspan="1">OS</td>
              <td valign="top" align="center" rowspan="1" colspan="1">34</td>
              <td valign="top" align="left" rowspan="1" colspan="1">
                <xref rid="B5" ref-type="bibr">Boelens et al., 2009</xref>
              </td>
            </tr>
            <tr>
              <td valign="top" align="left" rowspan="1" colspan="1">Nagoya</td>
              <td valign="top" align="center" rowspan="1" colspan="1">GSE13213</td>
              <td valign="top" align="center" rowspan="1" colspan="1">GPL6480</td>
              <td valign="top" align="center" rowspan="1" colspan="1">AD</td>
              <td valign="top" align="center" rowspan="1" colspan="1">OS</td>
              <td valign="top" align="center" rowspan="1" colspan="1">117</td>
              <td valign="top" align="left" rowspan="1" colspan="1">
                <xref rid="B47" ref-type="bibr">Tomida et al., 2009</xref>
              </td>
            </tr>
            <tr>
              <td valign="top" align="left" rowspan="1" colspan="1">Toronto</td>
              <td valign="top" align="center" rowspan="1" colspan="1">GSE14814</td>
              <td valign="top" align="center" rowspan="1" colspan="1">GPL96</td>
              <td valign="top" align="center" rowspan="1" colspan="1">AD/SCC/NOS</td>
              <td valign="top" align="center" rowspan="1" colspan="1">OS/DSS</td>
              <td valign="top" align="center" rowspan="1" colspan="1">133</td>
              <td valign="top" align="left" rowspan="1" colspan="1">
                <xref rid="B62" ref-type="bibr">Zhu et al., 2010</xref>
              </td>
            </tr>
            <tr>
              <td valign="top" align="left" rowspan="1" colspan="1">Chapel Hill</td>
              <td valign="top" align="center" rowspan="1" colspan="1">GSE17710</td>
              <td valign="top" align="center" rowspan="1" colspan="1">GPL9053</td>
              <td valign="top" align="center" rowspan="1" colspan="1">SCC</td>
              <td valign="top" align="center" rowspan="1" colspan="1">OS/PFI</td>
              <td valign="top" align="center" rowspan="1" colspan="1">56</td>
              <td valign="top" align="left" rowspan="1" colspan="1">
                <xref rid="B52" ref-type="bibr">Wilkerson et al., 2010</xref>
              </td>
            </tr>
            <tr>
              <td valign="top" align="left" rowspan="1" colspan="1">Rotterdam</td>
              <td valign="top" align="center" rowspan="1" colspan="1">GSE19188</td>
              <td valign="top" align="center" rowspan="1" colspan="1">GPL570</td>
              <td valign="top" align="center" rowspan="1" colspan="1">AD/SCC/LCC</td>
              <td valign="top" align="center" rowspan="1" colspan="1">OS</td>
              <td valign="top" align="center" rowspan="1" colspan="1">82</td>
              <td valign="top" align="left" rowspan="1" colspan="1">
                <xref rid="B18" ref-type="bibr">Hou et al., 2010</xref>
              </td>
            </tr>
            <tr>
              <td valign="top" align="left" rowspan="1" colspan="1">Chapel Hill</td>
              <td valign="top" align="center" rowspan="1" colspan="1">GSE26939</td>
              <td valign="top" align="center" rowspan="1" colspan="1">GPL9053</td>
              <td valign="top" align="center" rowspan="1" colspan="1">AD</td>
              <td valign="top" align="center" rowspan="1" colspan="1">OS</td>
              <td valign="top" align="center" rowspan="1" colspan="1">116</td>
              <td valign="top" align="left" rowspan="1" colspan="1">
                <xref rid="B53" ref-type="bibr">Wilkerson et al., 2012</xref>
              </td>
            </tr>
            <tr>
              <td valign="top" align="left" rowspan="1" colspan="1">Dallas</td>
              <td valign="top" align="center" rowspan="1" colspan="1">GSE29013</td>
              <td valign="top" align="center" rowspan="1" colspan="1">GPL570</td>
              <td valign="top" align="center" rowspan="1" colspan="1">AD/SCC</td>
              <td valign="top" align="center" rowspan="1" colspan="1">OS/PFI</td>
              <td valign="top" align="center" rowspan="1" colspan="1">55</td>
              <td valign="top" align="left" rowspan="1" colspan="1">
                <xref rid="B57" ref-type="bibr">Xie et al., 2011</xref>
              </td>
            </tr>
            <tr>
              <td valign="top" align="left" rowspan="1" colspan="1">Lund</td>
              <td valign="top" align="center" rowspan="1" colspan="1">GSE29066</td>
              <td valign="top" align="center" rowspan="1" colspan="1">GPL6947</td>
              <td valign="top" align="center" rowspan="1" colspan="1">AD/SCC/SCLC</td>
              <td valign="top" align="center" rowspan="1" colspan="1">OS</td>
              <td valign="top" align="center" rowspan="1" colspan="1">68</td>
              <td valign="top" align="left" rowspan="1" colspan="1"><xref rid="B41" ref-type="bibr">Staaf et al., 2012</xref>, <xref rid="B40" ref-type="bibr">2013</xref></td>
            </tr>
            <tr>
              <td valign="top" align="left" rowspan="1" colspan="1">La Tronche</td>
              <td valign="top" align="center" rowspan="1" colspan="1">GSE30219</td>
              <td valign="top" align="center" rowspan="1" colspan="1">GPL570</td>
              <td valign="top" align="center" rowspan="1" colspan="1">AD/SCC/SCLC/LCC</td>
              <td valign="top" align="center" rowspan="1" colspan="1">OS/DFS</td>
              <td valign="top" align="center" rowspan="1" colspan="1">293</td>
              <td valign="top" align="left" rowspan="1" colspan="1">
                <xref rid="B37" ref-type="bibr">Rousseaux et al., 2013</xref>
              </td>
            </tr>
            <tr>
              <td valign="top" align="left" rowspan="1" colspan="1">Chuo-ku</td>
              <td valign="top" align="center" rowspan="1" colspan="1">GSE31210</td>
              <td valign="top" align="center" rowspan="1" colspan="1">GPL570</td>
              <td valign="top" align="center" rowspan="1" colspan="1">AD</td>
              <td valign="top" align="center" rowspan="1" colspan="1">OS/PFI</td>
              <td valign="top" align="center" rowspan="1" colspan="1">226</td>
              <td valign="top" align="left" rowspan="1" colspan="1">
                <xref rid="B32" ref-type="bibr">Okayama et al., 2012</xref>
              </td>
            </tr>
            <tr>
              <td valign="top" align="left" rowspan="1" colspan="1">Durham</td>
              <td valign="top" align="center" rowspan="1" colspan="1">GSE3141</td>
              <td valign="top" align="center" rowspan="1" colspan="1">GPL570</td>
              <td valign="top" align="center" rowspan="1" colspan="1">AD/SCC</td>
              <td valign="top" align="center" rowspan="1" colspan="1">OS</td>
              <td valign="top" align="center" rowspan="1" colspan="1">111</td>
              <td valign="top" align="left" rowspan="1" colspan="1">
                <xref rid="B4" ref-type="bibr">Bild et al., 2006</xref>
              </td>
            </tr>
            <tr>
              <td valign="top" align="left" rowspan="1" colspan="1">Dallas</td>
              <td valign="top" align="center" rowspan="1" colspan="1">GSE31908</td>
              <td valign="top" align="center" rowspan="1" colspan="1">GPL96/97</td>
              <td valign="top" align="center" rowspan="1" colspan="1">AD</td>
              <td valign="top" align="center" rowspan="1" colspan="1">OS</td>
              <td valign="top" align="center" rowspan="1" colspan="1">30</td>
              <td valign="top" align="left" rowspan="1" colspan="1">NA</td>
            </tr>
            <tr>
              <td valign="top" align="left" rowspan="1" colspan="1">Houston</td>
              <td valign="top" align="center" rowspan="1" colspan="1">GSE33072</td>
              <td valign="top" align="center" rowspan="1" colspan="1">GPL6244</td>
              <td valign="top" align="center" rowspan="1" colspan="1">AD/SCC</td>
              <td valign="top" align="center" rowspan="1" colspan="1">PFI</td>
              <td valign="top" align="center" rowspan="1" colspan="1">66</td>
              <td valign="top" align="left" rowspan="1" colspan="1">
                <xref rid="B8" ref-type="bibr">Byers et al., 2013</xref>
              </td>
            </tr>
            <tr>
              <td valign="top" align="left" rowspan="1" colspan="1">Uppsala</td>
              <td valign="top" align="center" rowspan="1" colspan="1">GSE37745</td>
              <td valign="top" align="center" rowspan="1" colspan="1">GPL570</td>
              <td valign="top" align="center" rowspan="1" colspan="1">AD/SCC/LCC</td>
              <td valign="top" align="center" rowspan="1" colspan="1">PFI</td>
              <td valign="top" align="center" rowspan="1" colspan="1">196</td>
              <td valign="top" align="left" rowspan="1" colspan="1">
                <xref rid="B6" ref-type="bibr">Botling et al., 2013</xref>
              </td>
            </tr>
            <tr>
              <td valign="top" align="left" rowspan="1" colspan="1">Dallas</td>
              <td valign="top" align="center" rowspan="1" colspan="1">GSE41271</td>
              <td valign="top" align="center" rowspan="1" colspan="1">GPL6884</td>
              <td valign="top" align="center" rowspan="1" colspan="1">AD/SCC/LCC</td>
              <td valign="top" align="center" rowspan="1" colspan="1">OS/PFI</td>
              <td valign="top" align="center" rowspan="1" colspan="1">275</td>
              <td valign="top" align="left" rowspan="1" colspan="1">
                <xref rid="B38" ref-type="bibr">Sato et al., 2013</xref>
              </td>
            </tr>
            <tr>
              <td valign="top" align="left" rowspan="1" colspan="1">San Diego</td>
              <td valign="top" align="center" rowspan="1" colspan="1">GSE4573</td>
              <td valign="top" align="center" rowspan="1" colspan="1">GPL96</td>
              <td valign="top" align="center" rowspan="1" colspan="1">SCC</td>
              <td valign="top" align="center" rowspan="1" colspan="1">OS</td>
              <td valign="top" align="center" rowspan="1" colspan="1">130</td>
              <td valign="top" align="left" rowspan="1" colspan="1">
                <xref rid="B34" ref-type="bibr">Raponi et al., 2006</xref>
              </td>
            </tr>
            <tr>
              <td valign="top" align="left" rowspan="1" colspan="1">Nagoya</td>
              <td valign="top" align="center" rowspan="1" colspan="1">GSE4716</td>
              <td valign="top" align="center" rowspan="1" colspan="1">GPL3696/3694</td>
              <td valign="top" align="center" rowspan="1" colspan="1">AD/SCC/LCC</td>
              <td valign="top" align="center" rowspan="1" colspan="1">OS</td>
              <td valign="top" align="center" rowspan="1" colspan="1">50</td>
              <td valign="top" align="left" rowspan="1" colspan="1">
                <xref rid="B46" ref-type="bibr">Tomida et al., 2004</xref>
              </td>
            </tr>
            <tr>
              <td valign="top" align="left" rowspan="1" colspan="1">Toronto</td>
              <td valign="top" align="center" rowspan="1" colspan="1">GSE50081</td>
              <td valign="top" align="center" rowspan="1" colspan="1">GPL570</td>
              <td valign="top" align="center" rowspan="1" colspan="1">AD/SCC/LCC</td>
              <td valign="top" align="center" rowspan="1" colspan="1">OS/DFS</td>
              <td valign="top" align="center" rowspan="1" colspan="1">181</td>
              <td valign="top" align="left" rowspan="1" colspan="1">
                <xref rid="B9" ref-type="bibr">Der et al., 2014</xref>
              </td>
            </tr>
            <tr>
              <td valign="top" align="left" rowspan="1" colspan="1">Brisbane</td>
              <td valign="top" align="center" rowspan="1" colspan="1">GSE5123</td>
              <td valign="top" align="center" rowspan="1" colspan="1">GPL3877</td>
              <td valign="top" align="center" rowspan="1" colspan="1">SCC</td>
              <td valign="top" align="center" rowspan="1" colspan="1">OS</td>
              <td valign="top" align="center" rowspan="1" colspan="1">51</td>
              <td valign="top" align="left" rowspan="1" colspan="1">
                <xref rid="B23" ref-type="bibr">Larsen et al., 2007b</xref>
              </td>
            </tr>
            <tr>
              <td valign="top" align="left" rowspan="1" colspan="1">Brisbane</td>
              <td valign="top" align="center" rowspan="1" colspan="1">GSE5828</td>
              <td valign="top" align="center" rowspan="1" colspan="1">GPL3877</td>
              <td valign="top" align="center" rowspan="1" colspan="1">SCC</td>
              <td valign="top" align="center" rowspan="1" colspan="1">OS</td>
              <td valign="top" align="center" rowspan="1" colspan="1">59</td>
              <td valign="top" align="left" rowspan="1" colspan="1">
                <xref rid="B22" ref-type="bibr">Larsen et al., 2007a</xref>
              </td>
            </tr>
            <tr>
              <td valign="top" align="left" rowspan="1" colspan="1">Brisbane</td>
              <td valign="top" align="center" rowspan="1" colspan="1">GSE5843</td>
              <td valign="top" align="center" rowspan="1" colspan="1">GPL3877</td>
              <td valign="top" align="center" rowspan="1" colspan="1">AD</td>
              <td valign="top" align="center" rowspan="1" colspan="1">OS</td>
              <td valign="top" align="center" rowspan="1" colspan="1">48</td>
              <td valign="top" align="left" rowspan="1" colspan="1">
                <xref rid="B24" ref-type="bibr">Larsen et al., 2007c</xref>
              </td>
            </tr>
            <tr>
              <td valign="top" align="left" rowspan="1" colspan="1">St. Louis</td>
              <td valign="top" align="center" rowspan="1" colspan="1">GSE6253</td>
              <td valign="top" align="center" rowspan="1" colspan="1">GPL8300</td>
              <td valign="top" align="center" rowspan="1" colspan="1">AD/SCC/NOS</td>
              <td valign="top" align="center" rowspan="1" colspan="1">DSS</td>
              <td valign="top" align="center" rowspan="1" colspan="1">34</td>
              <td valign="top" align="left" rowspan="1" colspan="1">
                <xref rid="B27" ref-type="bibr">Lu et al., 2006</xref>
              </td>
            </tr>
            <tr>
              <td valign="top" align="left" rowspan="1" colspan="1">Bethesda</td>
              <td valign="top" align="center" rowspan="1" colspan="1">GSE63459</td>
              <td valign="top" align="center" rowspan="1" colspan="1">GPL6883</td>
              <td valign="top" align="center" rowspan="1" colspan="1">AD</td>
              <td valign="top" align="center" rowspan="1" colspan="1">OS</td>
              <td valign="top" align="center" rowspan="1" colspan="1">33</td>
              <td valign="top" align="left" rowspan="1" colspan="1">
                <xref rid="B35" ref-type="bibr">Robles et al., 2015</xref>
              </td>
            </tr>
            <tr>
              <td valign="top" align="left" rowspan="1" colspan="1">Stanford</td>
              <td valign="top" align="center" rowspan="1" colspan="1">GSE67639</td>
              <td valign="top" align="center" rowspan="1" colspan="1">GPL570</td>
              <td valign="top" align="center" rowspan="1" colspan="1">AD/SCC/NOS</td>
              <td valign="top" align="center" rowspan="1" colspan="1">OS</td>
              <td valign="top" align="center" rowspan="1" colspan="1">1106</td>
              <td valign="top" align="left" rowspan="1" colspan="1">
                <xref rid="B13" ref-type="bibr">Gentles et al., 2015</xref>
              </td>
            </tr>
            <tr>
              <td valign="top" align="left" rowspan="1" colspan="1">Rockville</td>
              <td valign="top" align="center" rowspan="1" colspan="1">GSE68465</td>
              <td valign="top" align="center" rowspan="1" colspan="1">GPL96</td>
              <td valign="top" align="center" rowspan="1" colspan="1">AD</td>
              <td valign="top" align="center" rowspan="1" colspan="1">OS/PFI</td>
              <td valign="top" align="center" rowspan="1" colspan="1">442/363</td>
              <td valign="top" align="left" rowspan="1" colspan="1">
                <xref rid="B39" ref-type="bibr">Shedden et al., 2008</xref>
              </td>
            </tr>
            <tr>
              <td valign="top" align="left" rowspan="1" colspan="1">Rockville</td>
              <td valign="top" align="center" rowspan="1" colspan="1">GSE68571</td>
              <td valign="top" align="center" rowspan="1" colspan="1">GPL80</td>
              <td valign="top" align="center" rowspan="1" colspan="1">AD</td>
              <td valign="top" align="center" rowspan="1" colspan="1">OS</td>
              <td valign="top" align="center" rowspan="1" colspan="1">86</td>
              <td valign="top" align="left" rowspan="1" colspan="1">
                <xref rid="B3" ref-type="bibr">Beer et al., 2002</xref>
              </td>
            </tr>
            <tr>
              <td valign="top" align="left" rowspan="1" colspan="1">Seoul</td>
              <td valign="top" align="center" rowspan="1" colspan="1">GSE8894</td>
              <td valign="top" align="center" rowspan="1" colspan="1">GPL570</td>
              <td valign="top" align="center" rowspan="1" colspan="1">AD/SCC</td>
              <td valign="top" align="center" rowspan="1" colspan="1">PFI</td>
              <td valign="top" align="center" rowspan="1" colspan="1">138</td>
              <td valign="top" align="left" rowspan="1" colspan="1">
                <xref rid="B25" ref-type="bibr">Lee et al., 2008</xref>
              </td>
            </tr>
            <tr>
              <td valign="top" align="left" rowspan="1" colspan="1">NIH and NHGRI</td>
              <td valign="top" align="center" rowspan="1" colspan="1">TCGA</td>
              <td valign="top" align="center" rowspan="1" colspan="1">DCC</td>
              <td valign="top" align="center" rowspan="1" colspan="1">AD</td>
              <td valign="top" align="center" rowspan="1" colspan="1">OS/DSS/DFI/PFI</td>
              <td valign="top" align="center" rowspan="1" colspan="1">513/478/306/513</td>
              <td valign="top" align="left" rowspan="1" colspan="1"><xref rid="B45" ref-type="bibr">The Cancer Genome Atlas Research Network, 2014</xref>; <xref rid="B26" ref-type="bibr">Liu et al., 2018</xref></td>
            </tr>
            <tr>
              <td valign="top" align="left" rowspan="1" colspan="1">NIH and NHGRI</td>
              <td valign="top" align="center" rowspan="1" colspan="1">TCGA</td>
              <td valign="top" align="center" rowspan="1" colspan="1">DCC</td>
              <td valign="top" align="center" rowspan="1" colspan="1">SCC</td>
              <td valign="top" align="center" rowspan="1" colspan="1">OS/DSS/DFI/PFI</td>
              <td valign="top" align="center" rowspan="1" colspan="1">498/452/303/499</td>
              <td valign="top" align="left" rowspan="1" colspan="1"><xref rid="B16" ref-type="bibr">Hammerman et al., 2012</xref>; <xref rid="B44" ref-type="bibr">The Cancer Genome Atlas Research Network, 2012</xref>; <xref rid="B26" ref-type="bibr">Liu et al., 2018</xref></td>
            </tr>
            <tr>
              <td valign="top" align="left" rowspan="1" colspan="1">Reopman</td>
              <td valign="top" align="center" rowspan="1" colspan="1">Roepman</td>
              <td rowspan="1" colspan="1"/>
              <td valign="top" align="center" rowspan="1" colspan="1">AD/SCC/LCC/NOS</td>
              <td valign="top" align="center" rowspan="1" colspan="1">OS</td>
              <td valign="top" align="center" rowspan="1" colspan="1">172</td>
              <td valign="top" align="left" rowspan="1" colspan="1">
                <xref rid="B36" ref-type="bibr">Roepman et al., 2009</xref>
              </td>
            </tr>
          </tbody>
        </table>
        <table-wrap-foot>
          <attrib>
            <italic>NSCLC, non-small cell lung cancer; SCLC, small cell lung cancer; AD, adenocarcinoma; SCC, squamous cell carcinoma; LCC, large cell carcinoma; NOS, not otherwise specified; OS, overall survival; DSS, disease-specific survival; DFI, disease-free interval; PFI, progression-free interval.</italic>
          </attrib>
        </table-wrap-foot>
      </table-wrap>
    </sec>
    <sec id="S2.SS4">
      <title>Statistical Analysis</title>
      <p>The association of lung cancer clinical factors and survival outcomes was analyzed by GraphPad Prism 8.0 software. The Cox proportional hazards regression and Kaplan Meier plot functions from R package “survival” were used in the OSluca to determine the association between gene expression and survival. The <italic>P</italic> ≤ 0.05 was considered statistically significant.</p>
    </sec>
  </sec>
  <sec id="S3">
    <title>Results</title>
    <sec id="S3.SS1">
      <title>Clinical Characteristics of Lung Cancer Patients in OSluca</title>
      <p>To develop an online survival web server for lung cancer, we collected 35 published high-throughput profiling datasets of lung cancer with long-term follow-up information (2 TCGA datasets, 32 GEO datasets, and 1 Roepman dataset). TCGA comprises 513 lung adenocarcinoma cases and 499 squamous cell carcinoma cases (<xref rid="T1" ref-type="table">Tables 1</xref>, <xref rid="T2" ref-type="table">2</xref>). GEO cohorts and Roepman cohort had more than 4,000 samples and 172 samples, respectively, as shown in <xref rid="T2" ref-type="table">Table 2</xref>. 4,901 patients have OS (overall survival) data; 2,176 patients have DSS (disease-specific survival) data; and 2,075 patients have PFI (progression-free interval or recurrence-free survival) data, while 608 patients have DFI (disease-free interval) data. The results showed that the patients with lung adenocarcinoma significantly survive longer than those of other histological lung cancer, and small cell lung cancer is associated with the worst prognosis compared to other types of lung cancer (<xref ref-type="fig" rid="F1">Figure 1A</xref>). Moreover, other clinical characteristics can also prominently affect patients’ prognosis, such as gender (<italic>P</italic> &lt; 0.0001), stage (<italic>P</italic> &lt; 0.0001), p-TNM stage (<italic>P</italic> &lt; 0.0001), and smoking status (<italic>P</italic> &lt; 0.0001) (<xref ref-type="fig" rid="F1">Figures 1B–E</xref>). Besides, these risk factors can influence other survival endpoints, such as PFI (data not shown). These results are in accordance with previous researches (<xref rid="B28" ref-type="bibr">Mao et al., 2016</xref>; <xref rid="B7" ref-type="bibr">Bray et al., 2018</xref>).</p>
      <fig id="F1" position="float">
        <label>FIGURE 1</label>
        <caption>
          <p>Correlation between the clinico-pathologic characteristics and overall survival of lung cancer in Online Consensus Survival for Lung Cancer (OSluca). <bold>(A)</bold> Correlation between histological types and OS. <bold>(B)</bold> Correlation between gender and OS. <bold>(C)</bold> Correlation between tumor stages and OS. <bold>(D)</bold> Correlation between p-TNM stages and OS. <bold>(E)</bold> Correlation between smoking status and OS. OS, overall survival; AD, adenocarcinoma; SCC, squamous cell carcinoma; LCC, large cell cancer.</p>
        </caption>
        <graphic xlink:href="fgene-11-00420-g001"/>
      </fig>
    </sec>
    <sec id="S3.SS2">
      <title>Construction and Usage of Prognostic Web Server OSluca</title>
      <p>Online consensus Survival for Lung Cancer includes a set of optional clinico-pathological factors, such as age, sex, histological type, grade, smoking status, and so on. Four survival endpoints can be selected basing on original patient outcomes, containing OS, DSS, DFI, and PFI (<xref rid="B26" ref-type="bibr">Liu et al., 2018</xref>). In order to make the user clearly see the prognostic effect of interested gene, a meta-analysis is to summarize the prognostic value for each gene on the home page of OSluca. Briefly, after the user types the official gene symbol into the input box on the home page, OSluca will display the survival analysis summary with a forest plot and a table from Cox proportional regression in each cohort and combined cohorts (combining all the datasets together). Take the tumor suppressor gene <italic>TP53</italic> (tumor protein p53) as an example and type “TP53” into the gene symbol box and click on “Survival analysis” (<xref ref-type="fig" rid="F1">Figure 2A</xref>, left). The meta-analysis results with a forest plot and a survival table for the <italic>TP53</italic> gene, will display the <italic>P</italic>-value and HR with 95% CI of each cohort and the combined cohorts (<xref ref-type="fig" rid="F2">Figure 2A</xref>, right). Then, the user can easily obtain KM plots of separate cohorts such as GSE30219 dataset by clicking on the “Go” button in the survival table (<xref ref-type="fig" rid="F2">Figure 2B</xref>). In addition, it is also available to use a subgroup of certain cohort to obtain specific prognostic information with selectable risk factors, such as cutoff value, histological type, grade, etc. Briefly, OSluca can output survival rates displaying a forest plot and a survival table with KM plot and <italic>P</italic>-value to measure the association between the investigated gene and survival rate.</p>
      <fig id="F2" position="float">
        <label>FIGURE 2</label>
        <caption>
          <p>The output home page and KM output web subpage in OSluca for lung cancer. <bold>(A)</bold> Home page of OSluca with <italic>TP53</italic> gene survival analysis, containing prognostic meta-analysis of a forest plot and a survival table. <bold>(B)</bold> KM plots of <italic>TP53</italic> gene in the GSE30219 cohort. Note: the cutoff value is the upper 25% vs. other 75%. The “Combined” in forest plot and survival table means the overall prognostic significance of inputted gene in a pooling cohort with all the datasets. TP53, tumor protein p53.</p>
        </caption>
        <graphic xlink:href="fgene-11-00420-g002"/>
      </fig>
    </sec>
    <sec id="S3.SS3">
      <title>Validation of Previously Reported Lung Cancer Prognostic Biomarkers in OSluca</title>
      <p>A search for lung cancer biomarkers was performed using a set of keywords in NCBI PubMed, including “lung cancer,” “survival,” “biomarker,” and “prognosis.” In total, we collected 104 published lung cancer prognostic biomarkers verified by IHC or qPCR (<xref ref-type="supplementary-material" rid="TS1">Supplementary Table S1</xref>) to evaluate the performance of OSluca. For example, Hsu et al. reported that <italic>ERO1L</italic> (ERO1-like protein alpha, also named <italic>ERO1A</italic>) is significantly overexpressed in tumor tissue and could be as a poor prognostic biomarker for lung adenocarcinoma (<xref rid="B19" ref-type="bibr">Hsu et al., 2016</xref>). The prognostic analysis of <italic>ERO1L</italic> in OSluca showed that high expression of <italic>ERO1L</italic> gene is significantly associated with poor outcome in eight out of nine cohorts (Top 9 cohorts, the sample size above 150 cases) (<xref ref-type="fig" rid="F3">Figures 3A–H</xref>), except the Roepman dataset (<xref ref-type="fig" rid="F3">Figure 3I</xref>). Next, each published biomarker was investigated in the Top 9 cohorts in OSluca, and the results showed that approximately 66% of biomarkers (69/104) were consistent with original published findings (<xref ref-type="supplementary-material" rid="TS1">Supplementary Table S1</xref>). Meanwhile, OSluca can be used to perform the outcome meta-analysis of the interested gene that showed that 14% (14/104) (<xref ref-type="supplementary-material" rid="TS1">Supplementary Table S1</xref>) of published prognostic genes have the similar prognostic values in one or multiple OSluca cohorts as reported in the literature, but these genes also showed the opposite outcomes in some other cohorts from OSluca. These genes need further investigations, such as the <italic>DDIT3</italic> gene (<xref ref-type="supplementary-material" rid="FS1">Supplementary Figure S2</xref> and <xref ref-type="supplementary-material" rid="TS1">Supplementary Table S1</xref>). In contrast, there are some prognostic biomarkers, which have been shown different outcomes between OSluca and previous findings. A total of 9% of the published prognostic genes showed opposite outcome results between OSluca and literatures (9/104) (see <xref ref-type="supplementary-material" rid="TS1">Supplementary Table S1</xref>), suggesting that these genes need further validation. For example, the transcription factor <italic>KLF15</italic> (Krüppel-like factor 15) had been proven to be higher in tumor tissue than that of adjacent non-tumor tissue and played an important role in promoting proliferation and carcinoma diversification in lung adenocarcinoma, associated with poor prognostic outcome (<xref rid="B12" ref-type="bibr">Gao et al., 2017</xref>). It was not anticipated that the patients with high expression of <italic>KLF15</italic> have better survival than those with low expression (<xref ref-type="supplementary-material" rid="TS1">Supplementary Table S1</xref> and <xref ref-type="supplementary-material" rid="FS1">Supplementary Figure S1</xref>). The OSluca result for the <italic>KLF15</italic> gene was consistent with other prognostic analysis tools (<xref rid="B15" ref-type="bibr">Gyõrffy et al., 2013</xref>; <xref rid="B1" ref-type="bibr">Anaya, 2016</xref>), such as the KM plotter [<italic>P</italic> &lt; 0.001, HR (95% CI) = 0.4 (0.28–0.58)]. In addition, the remaining 12 of 104 previously published prognostic biomarkers (11%) were not significant for prognostic analysis in the Top 9 cohorts in OSluca, but 8 of them (8/12) are significant in one or multiple datasets other than the Top 9 cohorts in OSluca (data not shown). All in all, the OSluca server is an interactive and free web server for researchers to develop potential prognostic biomarkers for lung cancer.</p>
      <fig id="F3" position="float">
        <label>FIGURE 3</label>
        <caption>
          <p>Validation of a previously reported biomarker <italic>ERO1L</italic> in OSluca. Overexpression of <italic>ERO1L</italic> in tumor tissue is suggested as a worse survival biomarker in lung adenocarcinoma. <bold>(A)</bold> Overall survival (OS) of <italic>ERO1L</italic> gene in GSE30219 cohort. <bold>(B)</bold> OS in GSE31210 cohort. <bold>(C)</bold> OS in GSE37745 cohort. <bold>(D)</bold> OS in GSE41271 cohort. <bold>(E)</bold> OS in GSE50081 cohort. <bold>(F)</bold> OS in GSE67639 cohort. <bold>(G)</bold> OS in GSE68465 cohort. <bold>(H)</bold> OS in TCGA in lung adenocarcinoma. <bold>(I)</bold> OS in Roepman cohort. The histological type of all the above cohorts is lung adenocarcinoma. ERO1L, ERO1-like protein alpha (also named ERO1A).</p>
        </caption>
        <graphic xlink:href="fgene-11-00420-g003"/>
      </fig>
    </sec>
  </sec>
  <sec id="S4">
    <title>Discussion</title>
    <p>Owing to tumor molecular heterogeneity, the prognosis of lung cancer patients is variable and difficult to predict. The prognosis of patients suffering from lung cancer had been demonstrated to be highly dependent on clinical factors of the patient, such as histological type, smoking status, and so on. However, it is also an imperative need to exploit novel prognostic biomarkers for determining the risk of cancerous lesions and predicting lung cancer patient outcomes by all available means, especially by high-throughput sequencing technologies. However, one major challenge to non-bioinformatics researchers is how to integrate the high-dimension profiling datasets of lung cancer and discover new biomarkers to potentially guide prognostic stratification. Previous studies had revealed that the online prognostic web servers of cancer (<xref rid="B11" ref-type="bibr">Elfilali et al., 2006</xref>; <xref rid="B31" ref-type="bibr">Mizuno et al., 2009</xref>; <xref rid="B14" ref-type="bibr">Goswami and Nakshatri, 2013</xref>; <xref rid="B15" ref-type="bibr">Gyõrffy et al., 2013</xref>; <xref rid="B43" ref-type="bibr">Tang et al., 2017</xref>) could substantially help researchers to discover potential biomarkers (<xref rid="B61" ref-type="bibr">Zheng et al., 2020</xref>). Herein, we developed a free web server OSluca to assess the prognostic value of the interesting gene in multiple cohorts of lung cancers. In OSluca, all the lung cancer cases are originated from the organ lung, not the second cancer from other cancers or organs. As a result, the prognostic specificity is only for lung cancer. Nevertheless, its prognostic significance in other types of cancers is also worth to be determined. To access the repeatability of previously reported prognostic biomarkers in OSluca, we collected 104 previously published prognostic biomarkers of lung cancer identified by qPCR or IHC, and tested their prognostic significance in OSluca. The testing results showed that most of the biomarkers were verified in OSluca and were confirmed for the published findings. Nevertheless, some genes showed different prognostic outcomes compared to previous literatures.</p>
    <p>The advantage of OSluca over other online prognostic web servers is that the size of lung cancer samples in OSluca is large, and tens of independent cohorts are available, which is extremely valuable for the identification and validation of cancer prognostic biomarkers, since the most important part for the biomarker development is independent validation across different datasets/cohorts. The limitation of the current study is that OSluca can only test a single gene for outcome analysis. In summary, OSluca is a free web server for non-bioinformatics researchers to study potential lung cancer prognostic biomarkers, accessed at <ext-link ext-link-type="uri" xlink:href="http://bioinfo.henu.edu.cn/LUCA/LUCAList.jsp">http://bioinfo.henu.edu.cn/LUCA/LUCAList.jsp</ext-link>.</p>
  </sec>
  <sec sec-type="data-availability" id="S5">
    <title>Data Availability Statement</title>
    <p>The datasets generated for this study can be found in the TCGA, NCBI GEO, and Roepman dataset.</p>
  </sec>
  <sec id="S6">
    <title>Author Contributions</title>
    <p>XG: research design. QW and XG: establish OSluca web server. ZY, ZL, and XS: deal with RNA sequencing with clinical data of lung cancer. ZY, LX, XS, LZ, YL, and XG: draft of the manuscript. YD, XS, LZ, PS, YL, TX, and JM: collect previously reported biomarkers of lung cancer. ZY, LX, LZ, WZ, YZ, and XG: critical revision of the manuscript.</p>
  </sec>
  <sec id="conf1">
    <title>Conflict of Interest</title>
    <p>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</p>
  </sec>
</body>
<back>
  <fn-group>
    <fn fn-type="financial-disclosure">
      <p><bold>Funding.</bold> This study was supported by the following funding: The Kaifeng Science and Technology Major Project (18ZD008), the National Natural Science Foundation of China (Nos. 81602362 and 81801569), the Program for Science and Technology Development in Henan Province (Nos. 162102310391, 172102210187, and 192102310302), the Program for Young Key Teacher of Henan Province (2016GGJS-214), the supporting grants of Henan University (Nos. 2015YBZR048 and B2015151), and the Yellow River Scholar Program (No. H2016012).</p>
    </fn>
  </fn-group>
  <fn-group>
    <fn id="footnote1">
      <label>1</label>
      <p>
        <ext-link ext-link-type="uri" xlink:href="https://cancergenome.nih.gov/">https://cancergenome.nih.gov/</ext-link>
      </p>
    </fn>
    <fn id="footnote2">
      <label>2</label>
      <p>
        <ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/geo/">www.ncbi.nlm.nih.gov/geo/</ext-link>
      </p>
    </fn>
  </fn-group>
  <sec id="S8" sec-type="supplementary material">
    <title>Supplementary Material</title>
    <p>The Supplementary Material for this article can be found online at: <ext-link ext-link-type="uri" xlink:href="https://www.frontiersin.org/articles/10.3389/fgene.2020.00420/full#supplementary-material">https://www.frontiersin.org/articles/10.3389/fgene.2020.00420/full#supplementary-material</ext-link></p>
    <supplementary-material content-type="local-data" id="FS1">
      <media xlink:href="Data_Sheet_1.DOCX">
        <caption>
          <p>Click here for additional data file.</p>
        </caption>
      </media>
    </supplementary-material>
    <supplementary-material content-type="local-data" id="TS1">
      <media xlink:href="Table_1.XLSX">
        <caption>
          <p>Click here for additional data file.</p>
        </caption>
      </media>
    </supplementary-material>
  </sec>
  <ref-list>
    <title>References</title>
    <ref id="B1">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Anaya</surname><given-names>J.</given-names></name></person-group> (<year>2016</year>). <article-title>OncoLnc: linking TCGA survival data to mRNAs, miRNAs, and lncRNAs.</article-title>
<source><italic>Peerj Comput. Sci.</italic></source>
<volume>2</volume>:<issue>e67</issue>.</mixed-citation>
    </ref>
    <ref id="B2">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Baty</surname><given-names>F.</given-names></name><name><surname>Facompre</surname><given-names>M.</given-names></name><name><surname>Kaiser</surname><given-names>S.</given-names></name><name><surname>Schumacher</surname><given-names>M.</given-names></name><name><surname>Pless</surname><given-names>M.</given-names></name><name><surname>Bubendorf</surname><given-names>L.</given-names></name><etal/></person-group> (<year>2010</year>). <article-title>Gene profiling of clinical routine biopsies and prediction of survival in non-small cell lung cancer.</article-title>
<source><italic>Am. J. Respir. Crit. Care Med.</italic></source>
<volume>181</volume>
<fpage>181</fpage>–<lpage>188</lpage>. <pub-id pub-id-type="doi">10.1164/rccm.200812-1807OC</pub-id><pub-id pub-id-type="pmid">19833826</pub-id></mixed-citation>
    </ref>
    <ref id="B3">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Beer</surname><given-names>D. G.</given-names></name><name><surname>Kardia</surname><given-names>S. L.</given-names></name><name><surname>Huang</surname><given-names>C. C.</given-names></name><name><surname>Giordano</surname><given-names>T. J.</given-names></name><name><surname>Levin</surname><given-names>A. M.</given-names></name><name><surname>Misek</surname><given-names>D. E.</given-names></name><etal/></person-group> (<year>2002</year>). <article-title>Gene-expression profiles predict survival of patients with lung adenocarcinoma.</article-title>
<source><italic>Nat. Med.</italic></source>
<volume>8</volume>
<fpage>816</fpage>–<lpage>824</lpage>. <pub-id pub-id-type="doi">10.1038/nm733</pub-id>
<?supplied-pmid 12118244?><pub-id pub-id-type="pmid">12118244</pub-id></mixed-citation>
    </ref>
    <ref id="B4">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bild</surname><given-names>A. H.</given-names></name><name><surname>Yao</surname><given-names>G.</given-names></name><name><surname>Chang</surname><given-names>J. T.</given-names></name><name><surname>Wang</surname><given-names>Q.</given-names></name><name><surname>Potti</surname><given-names>A.</given-names></name><name><surname>Chasse</surname><given-names>D.</given-names></name><etal/></person-group> (<year>2006</year>). <article-title>Oncogenic pathway signatures in human cancers as a guide to targeted therapies.</article-title>
<source><italic>Nature</italic></source>
<volume>439</volume>
<fpage>353</fpage>–<lpage>357</lpage>. <pub-id pub-id-type="doi">10.1038/nature04296</pub-id><pub-id pub-id-type="pmid">16273092</pub-id></mixed-citation>
    </ref>
    <ref id="B5">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Boelens</surname><given-names>M. C.</given-names></name><name><surname>van den Berg</surname><given-names>A.</given-names></name><name><surname>Fehrmann</surname><given-names>R. S.</given-names></name><name><surname>Geerlings</surname><given-names>M.</given-names></name><name><surname>de Jong</surname><given-names>W. K.</given-names></name><name><surname>te Meerman</surname><given-names>G. J.</given-names></name><etal/></person-group> (<year>2009</year>). <article-title>Current smoking-specific gene expression signature in normal bronchial epithelium is enhanced in squamous cell lung cancer.</article-title>
<source><italic>J. Pathol.</italic></source>
<volume>218</volume>
<fpage>182</fpage>–<lpage>191</lpage>. <pub-id pub-id-type="doi">10.1002/path.2520</pub-id><pub-id pub-id-type="pmid">19334046</pub-id></mixed-citation>
    </ref>
    <ref id="B6">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Botling</surname><given-names>J.</given-names></name><name><surname>Edlund</surname><given-names>K.</given-names></name><name><surname>Lohr</surname><given-names>M.</given-names></name><name><surname>Hellwig</surname><given-names>B.</given-names></name><name><surname>Holmberg</surname><given-names>L.</given-names></name><name><surname>Lambe</surname><given-names>M.</given-names></name><etal/></person-group> (<year>2013</year>). <article-title>Biomarker discovery in Non–small cell lung cancer: integrating gene expression profiling, meta-analysis, and tissue microarray validation.</article-title>
<source><italic>Clin. Cancer Res.</italic></source>
<volume>19</volume>
<fpage>194</fpage>–<lpage>204</lpage>. <pub-id pub-id-type="doi">10.1158/1078-0432.ccr-12-1139</pub-id><pub-id pub-id-type="pmid">23032747</pub-id></mixed-citation>
    </ref>
    <ref id="B7">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bray</surname><given-names>F.</given-names></name><name><surname>Ferlay</surname><given-names>J.</given-names></name><name><surname>Soerjomataram</surname><given-names>I.</given-names></name><name><surname>Siegel</surname><given-names>R. L.</given-names></name><name><surname>Torre</surname><given-names>L. A.</given-names></name><name><surname>Jemal</surname><given-names>A.</given-names></name></person-group> (<year>2018</year>). <article-title>Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries.</article-title>
<source><italic>Cancer J. Clin.</italic></source>
<volume>68</volume>
<fpage>394</fpage>–<lpage>424</lpage>. <pub-id pub-id-type="doi">10.3322/caac.21492</pub-id>
<?supplied-pmid 30207593?><pub-id pub-id-type="pmid">30207593</pub-id></mixed-citation>
    </ref>
    <ref id="B8">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Byers</surname><given-names>L. A.</given-names></name><name><surname>Diao</surname><given-names>L.</given-names></name><name><surname>Wang</surname><given-names>J.</given-names></name><name><surname>Saintigny</surname><given-names>P.</given-names></name><name><surname>Girard</surname><given-names>L.</given-names></name><name><surname>Peyton</surname><given-names>M.</given-names></name><etal/></person-group> (<year>2013</year>). <article-title>An epithelial-mesenchymal transition gene signature predicts resistance to EGFR and PI3K inhibitors and identifies Axl as a therapeutic target for overcoming EGFR inhibitor resistance.</article-title>
<source><italic>Clin. Cancer Res.</italic></source>
<volume>19</volume>
<fpage>279</fpage>–<lpage>290</lpage>. <pub-id pub-id-type="doi">10.1158/1078-0432.CCR-12-1558</pub-id><pub-id pub-id-type="pmid">23091115</pub-id></mixed-citation>
    </ref>
    <ref id="B9">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Der</surname><given-names>S. D.</given-names></name><name><surname>Sykes</surname><given-names>J.</given-names></name><name><surname>Pintilie</surname><given-names>M.</given-names></name><name><surname>Zhu</surname><given-names>C.-Q.</given-names></name><name><surname>Strumpf</surname><given-names>D.</given-names></name><name><surname>Liu</surname><given-names>N.</given-names></name><etal/></person-group> (<year>2014</year>). <article-title>Validation of a histology-independent prognostic gene signature for early-stage, non–small-cell lung cancer including stage IA patients.</article-title>
<source><italic>J. Thorac. Oncol.</italic></source>
<volume>9</volume>
<fpage>59</fpage>–<lpage>64</lpage>. <pub-id pub-id-type="doi">10.1097/JTO.0000000000000042</pub-id><pub-id pub-id-type="pmid">24305008</pub-id></mixed-citation>
    </ref>
    <ref id="B10">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dong</surname><given-names>H.</given-names></name><name><surname>Wang</surname><given-names>Q.</given-names></name><name><surname>Zhang</surname><given-names>G.</given-names></name><name><surname>Li</surname><given-names>N.</given-names></name><name><surname>Yang</surname><given-names>M.</given-names></name><name><surname>An</surname><given-names>Y.</given-names></name><etal/></person-group> (<year>2020</year>). <article-title>OSdlbcl: an online consensus survival analysis web server based on gene expression profiles of diffuse large B-cell lymphoma.</article-title>
<source><italic>Cancer Med.</italic></source>
<volume>9</volume>
<fpage>1790</fpage>–<lpage>1797</lpage>. <pub-id pub-id-type="doi">10.1002/cam4.2829</pub-id>
<?supplied-pmid 31918459?><pub-id pub-id-type="pmid">31918459</pub-id></mixed-citation>
    </ref>
    <ref id="B11">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Elfilali</surname><given-names>A.</given-names></name><name><surname>Lair</surname><given-names>S.</given-names></name><name><surname>Verbeke</surname><given-names>C.</given-names></name><name><surname>La Rosa</surname><given-names>P.</given-names></name><name><surname>Radvanyi</surname><given-names>F.</given-names></name><name><surname>Barillot</surname><given-names>E.</given-names></name></person-group> (<year>2006</year>). <article-title>ITTACA: a new database for integrated tumor transcriptome array and clinical data analysis.</article-title>
<source><italic>Nucleic Acids Res.</italic></source>
<volume>34</volume>
<fpage>D613</fpage>–<lpage>D616</lpage>. <pub-id pub-id-type="doi">10.1093/nar/gkj022</pub-id><pub-id pub-id-type="pmid">16381943</pub-id></mixed-citation>
    </ref>
    <ref id="B12">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gao</surname><given-names>L.</given-names></name><name><surname>Qiu</surname><given-names>H.</given-names></name><name><surname>Liu</surname><given-names>J.</given-names></name><name><surname>Ma</surname><given-names>Y.</given-names></name><name><surname>Feng</surname><given-names>J.</given-names></name><name><surname>Qian</surname><given-names>L.</given-names></name><etal/></person-group> (<year>2017</year>). <article-title>KLF15 promotes the proliferation and metastasis of lung adenocarcinoma cells and has potential as a cancer prognostic marker.</article-title>
<source><italic>Oncotarget</italic></source>
<volume>8</volume>
<fpage>109952</fpage>–<lpage>109961</lpage>. <pub-id pub-id-type="doi">10.18632/oncotarget.21972</pub-id><pub-id pub-id-type="pmid">29299121</pub-id></mixed-citation>
    </ref>
    <ref id="B13">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gentles</surname><given-names>A. J.</given-names></name><name><surname>Bratman</surname><given-names>S. V.</given-names></name><name><surname>Lee</surname><given-names>L. J.</given-names></name><name><surname>Harris</surname><given-names>J. P.</given-names></name><name><surname>Feng</surname><given-names>W.</given-names></name><name><surname>Nair</surname><given-names>R. V.</given-names></name><etal/></person-group> (<year>2015</year>). <article-title>Integrating tumor and stromal gene expression signatures with clinical indices for survival stratification of early-stage Non-small cell lung cancer.</article-title>
<source><italic>J. Natl. Inst.</italic></source>
<volume>107</volume>:<issue>djv211</issue>
<pub-id pub-id-type="doi">10.1093/jnci/djv211</pub-id></mixed-citation>
    </ref>
    <ref id="B14">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Goswami</surname><given-names>C. P.</given-names></name><name><surname>Nakshatri</surname><given-names>H.</given-names></name></person-group> (<year>2013</year>). <article-title>PROGgene: gene expression based survival analysis web application for multiple cancers.</article-title>
<source><italic>J. Clin. Bioinform.</italic></source>
<volume>3</volume>:<issue>22</issue>
<pub-id pub-id-type="doi">10.1186/2043-9113-3-22</pub-id></mixed-citation>
    </ref>
    <ref id="B15">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gyõrffy</surname><given-names>B.</given-names></name><name><surname>Surowiak</surname><given-names>P.</given-names></name><name><surname>Budczies</surname><given-names>J.</given-names></name><name><surname>Lánczky</surname><given-names>A.</given-names></name></person-group> (<year>2013</year>). <article-title>Online survival analysis software to assess the prognostic value of biomarkers using transcriptomic data in non-small-cell lung cancer.</article-title>
<source><italic>PLoS One</italic></source>
<volume>8</volume>:<issue>e82241</issue>
<pub-id pub-id-type="doi">10.1371/journal.pone.0082241</pub-id></mixed-citation>
    </ref>
    <ref id="B16">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hammerman</surname><given-names>P. S.</given-names></name><name><surname>Lawrence</surname><given-names>M. S.</given-names></name><name><surname>Voet</surname><given-names>D.</given-names></name><name><surname>Jing</surname><given-names>R.</given-names></name><name><surname>Cibulskis</surname><given-names>K.</given-names></name><name><surname>Sivachenko</surname><given-names>A.</given-names></name><etal/></person-group> (<year>2012</year>). <article-title>Comprehensive genomic characterization of squamous cell lung cancers.</article-title>
<source><italic>Nature</italic></source>
<volume>489</volume>
<fpage>519</fpage>–<lpage>525</lpage>. <pub-id pub-id-type="doi">10.1038/nature11404</pub-id><pub-id pub-id-type="pmid">22960745</pub-id></mixed-citation>
    </ref>
    <ref id="B17">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hoadley</surname><given-names>K. A.</given-names></name><name><surname>Yau</surname><given-names>C.</given-names></name><name><surname>Hinoue</surname><given-names>T.</given-names></name><name><surname>Wolf</surname><given-names>D. M.</given-names></name><name><surname>Lazar</surname><given-names>A. J.</given-names></name><name><surname>Drill</surname><given-names>E.</given-names></name><etal/></person-group> (<year>2018</year>). <article-title>Cell-of-origin patterns dominate the molecular classification of 10,000 tumors from 33 Types of cancer.</article-title>
<source><italic>Cell</italic></source>
<volume>173</volume>
<fpage>291.e6</fpage>–<lpage>304.e6</lpage>. <pub-id pub-id-type="doi">10.1016/j.cell.2018.03.022</pub-id>
<?supplied-pmid 29625048?><pub-id pub-id-type="pmid">29625048</pub-id></mixed-citation>
    </ref>
    <ref id="B18">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hou</surname><given-names>J.</given-names></name><name><surname>Aerts</surname><given-names>J.</given-names></name><name><surname>den Hamer</surname><given-names>B.</given-names></name><name><surname>van Ijcken</surname><given-names>W.</given-names></name><name><surname>den Bakker</surname><given-names>M.</given-names></name><name><surname>Riegman</surname><given-names>P.</given-names></name><etal/></person-group> (<year>2010</year>). <article-title>Gene expression-based classification of non-small cell lung carcinomas and survival prediction.</article-title>
<source><italic>PloS One</italic></source>
<volume>5</volume>:<issue>e10312</issue>
<pub-id pub-id-type="doi">10.1371/journal.pone.0010312</pub-id></mixed-citation>
    </ref>
    <ref id="B19">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hsu</surname><given-names>C.-H.</given-names></name><name><surname>Hsu</surname><given-names>C.-W.</given-names></name><name><surname>Hsueh</surname><given-names>C.</given-names></name><name><surname>Wang</surname><given-names>C.-L.</given-names></name><name><surname>Wu</surname><given-names>Y.-C.</given-names></name><name><surname>Wu</surname><given-names>C.-C.</given-names></name><etal/></person-group> (<year>2016</year>). <article-title>Identification and characterization of potential biomarkers by quantitative tissue proteomics of primary lung adenocarcinoma.</article-title>
<source><italic>Mol. Cell. Proteomics</italic></source>
<volume>15</volume>
<fpage>2396</fpage>–<lpage>2410</lpage>. <pub-id pub-id-type="doi">10.1074/mcp.M115.057026</pub-id><pub-id pub-id-type="pmid">27161446</pub-id></mixed-citation>
    </ref>
    <ref id="B20">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jones</surname><given-names>M. H.</given-names></name><name><surname>Virtanen</surname><given-names>C.</given-names></name><name><surname>Honjoh</surname><given-names>D.</given-names></name><name><surname>Miyoshi</surname><given-names>T.</given-names></name><name><surname>Satoh</surname><given-names>Y.</given-names></name><name><surname>Okumura</surname><given-names>S.</given-names></name><etal/></person-group> (<year>2004</year>). <article-title>Two prognostically significant subtypes of high-grade lung neuroendocrine tumours independent of small-cell and large-cell neuroendocrine carcinomas identified by gene expression profiles.</article-title>
<source><italic>Lancet</italic></source>
<volume>363</volume>
<fpage>775</fpage>–<lpage>781</lpage>. <pub-id pub-id-type="doi">10.1016/s0140-6736(04)15693-6</pub-id><pub-id pub-id-type="pmid">15016488</pub-id></mixed-citation>
    </ref>
    <ref id="B21">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kuner</surname><given-names>R.</given-names></name><name><surname>Muley</surname><given-names>T.</given-names></name><name><surname>Meister</surname><given-names>M.</given-names></name><name><surname>Ruschhaupt</surname><given-names>M.</given-names></name><name><surname>Buness</surname><given-names>A.</given-names></name><name><surname>Xu</surname><given-names>E. C.</given-names></name><etal/></person-group> (<year>2009</year>). <article-title>Global gene expression analysis reveals specific patterns of cell junctions in non-small cell lung cancer subtypes.</article-title>
<source><italic>Lung Cancer</italic></source>
<volume>63</volume>
<fpage>32</fpage>–<lpage>38</lpage>. <pub-id pub-id-type="doi">10.1016/j.lungcan.2008.03.033</pub-id><pub-id pub-id-type="pmid">18486272</pub-id></mixed-citation>
    </ref>
    <ref id="B22">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Larsen</surname><given-names>J. E.</given-names></name><name><surname>Pavey</surname><given-names>S. J.</given-names></name><name><surname>Bowman</surname><given-names>R.</given-names></name><name><surname>Yang</surname><given-names>I. A.</given-names></name><name><surname>Clarke</surname><given-names>B. E.</given-names></name><name><surname>Colosimo</surname><given-names>M. L.</given-names></name><etal/></person-group> (<year>2007a</year>). <article-title>Gene expression of lung squamous cell carcinoma reflects mode of lymph node involvement.</article-title>
<source><italic>Eur. Respir. J.</italic></source>
<volume>30</volume>
<fpage>21</fpage>–<lpage>25</lpage>. <pub-id pub-id-type="doi">10.1183/09031936.00161306</pub-id><pub-id pub-id-type="pmid">17601969</pub-id></mixed-citation>
    </ref>
    <ref id="B23">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Larsen</surname><given-names>J. E.</given-names></name><name><surname>Pavey</surname><given-names>S. J.</given-names></name><name><surname>Passmore</surname><given-names>L. H.</given-names></name><name><surname>Bowman</surname><given-names>R.</given-names></name><name><surname>Clarke</surname><given-names>B. E.</given-names></name><name><surname>Hayward</surname><given-names>N. K.</given-names></name><etal/></person-group> (<year>2007b</year>). <article-title>Expression profiling defines a recurrence signature in lung squamous cell carcinoma.</article-title>
<source><italic>Carcinogenesis</italic></source>
<volume>28</volume>
<fpage>760</fpage>–<lpage>766</lpage>. <pub-id pub-id-type="doi">10.1093/carcin/bgl207</pub-id><pub-id pub-id-type="pmid">17082175</pub-id></mixed-citation>
    </ref>
    <ref id="B24">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Larsen</surname><given-names>J. E.</given-names></name><name><surname>Pavey</surname><given-names>S. J.</given-names></name><name><surname>Passmore</surname><given-names>L. H.</given-names></name><name><surname>Bowman</surname><given-names>R. V.</given-names></name><name><surname>Hayward</surname><given-names>N. K.</given-names></name><name><surname>Fong</surname><given-names>K. M.</given-names></name></person-group> (<year>2007c</year>). <article-title>Gene expression signature predicts recurrence in lung adenocarcinoma.</article-title>
<source><italic>Clin. Cancer Res.</italic></source>
<volume>13</volume>
<fpage>2946</fpage>–<lpage>2954</lpage>. <pub-id pub-id-type="doi">10.1158/1078-0432.ccr-06-2525</pub-id><pub-id pub-id-type="pmid">17504995</pub-id></mixed-citation>
    </ref>
    <ref id="B25">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lee</surname><given-names>E.-S.</given-names></name><name><surname>Son</surname><given-names>D.-S.</given-names></name><name><surname>Kim</surname><given-names>S.-H.</given-names></name><name><surname>Lee</surname><given-names>J.</given-names></name><name><surname>Jo</surname><given-names>J.</given-names></name><name><surname>Han</surname><given-names>J.</given-names></name><etal/></person-group> (<year>2008</year>). <article-title>Prediction of recurrence-free survival in postoperative Non–small cell lung cancer patients by using an integrated model of clinical information and gene expression.</article-title>
<source><italic>Clin. Cancer Res.</italic></source>
<volume>14</volume>
<fpage>7397</fpage>–<lpage>7404</lpage>. <pub-id pub-id-type="doi">10.1158/1078-0432.ccr-07-4937</pub-id><pub-id pub-id-type="pmid">19010856</pub-id></mixed-citation>
    </ref>
    <ref id="B26">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Liu</surname><given-names>J.</given-names></name><name><surname>Lichtenberg</surname><given-names>T.</given-names></name><name><surname>Hoadley</surname><given-names>K. A.</given-names></name><name><surname>Poisson</surname><given-names>L. M.</given-names></name><name><surname>Lazar</surname><given-names>A. J.</given-names></name><name><surname>Cherniack</surname><given-names>A. D.</given-names></name><etal/></person-group> (<year>2018</year>). <article-title>An integrated tcga pan-cancer clinical data resource to drive high-quality survival outcome analytics.</article-title>
<source><italic>Cell</italic></source>
<volume>173</volume>
<fpage>400.e11</fpage>–<lpage>416.e11</lpage>. <pub-id pub-id-type="doi">10.1016/j.cell.2018.02.052</pub-id><pub-id pub-id-type="pmid">29625055</pub-id></mixed-citation>
    </ref>
    <ref id="B27">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lu</surname><given-names>Y.</given-names></name><name><surname>Lemon</surname><given-names>W.</given-names></name><name><surname>Liu</surname><given-names>P.-Y.</given-names></name><name><surname>Yi</surname><given-names>Y.</given-names></name><name><surname>Morrison</surname><given-names>C.</given-names></name><name><surname>Yang</surname><given-names>P.</given-names></name><etal/></person-group> (<year>2006</year>). <article-title>A gene expression signature predicts survival of patients with stage I non-small cell lung cancer.</article-title>
<source><italic>PLoS Med.</italic></source>
<volume>3</volume>:<issue>e030467</issue>
<pub-id pub-id-type="doi">10.1371/journal.pmed.0030467</pub-id></mixed-citation>
    </ref>
    <ref id="B28">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mao</surname><given-names>Y.</given-names></name><name><surname>Yang</surname><given-names>D.</given-names></name><name><surname>He</surname><given-names>J.</given-names></name><name><surname>Krasna</surname><given-names>M. J.</given-names></name></person-group> (<year>2016</year>). <article-title>Epidemiology of lung cancer.</article-title>
<source><italic>Surg. Oncol. Clin. North Am.</italic></source>
<volume>25</volume>
<fpage>439</fpage>–<lpage>445</lpage>. <pub-id pub-id-type="doi">10.1016/j.soc.2016.02.001</pub-id></mixed-citation>
    </ref>
    <ref id="B29">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Meyerson</surname><given-names>M.</given-names></name><name><surname>Carbone</surname><given-names>D.</given-names></name></person-group> (<year>2005</year>). <article-title>Genomic and proteomic profiling of lung cancers: lung cancer classification in the age of targeted therapy.</article-title>
<source><italic>J. Clin. Oncol.</italic></source>
<volume>23</volume>
<fpage>3219</fpage>–<lpage>3226</lpage>. <pub-id pub-id-type="doi">10.1200/JCO.2005.15.511</pub-id><pub-id pub-id-type="pmid">15886309</pub-id></mixed-citation>
    </ref>
    <ref id="B30">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mitchell</surname><given-names>K. A.</given-names></name><name><surname>Zingone</surname><given-names>A.</given-names></name><name><surname>Toulabi</surname><given-names>L.</given-names></name><name><surname>Boeckelman</surname><given-names>J.</given-names></name><name><surname>Ryan</surname><given-names>B. M.</given-names></name></person-group> (<year>2017</year>). <article-title>Comparative transcriptome profiling reveals coding and noncoding RNA differences in NSCLC from african americans and european americans.</article-title>
<source><italic>Clin. Res.</italic></source>
<volume>23</volume>
<fpage>7412</fpage>–<lpage>7425</lpage>. <pub-id pub-id-type="doi">10.1158/1078-0432.ccr-17-0527</pub-id></mixed-citation>
    </ref>
    <ref id="B31">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mizuno</surname><given-names>H.</given-names></name><name><surname>Kitada</surname><given-names>K.</given-names></name><name><surname>Nakai</surname><given-names>K.</given-names></name><name><surname>Sarai</surname><given-names>A.</given-names></name></person-group> (<year>2009</year>). <article-title>PrognoScan: a new database for meta-analysis of the prognostic value of genes.</article-title>
<source><italic>BMC Med. Genomics</italic></source>
<volume>2</volume>:<issue>18</issue>
<pub-id pub-id-type="doi">10.1186/1755-8794-2-18</pub-id></mixed-citation>
    </ref>
    <ref id="B32">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Okayama</surname><given-names>H.</given-names></name><name><surname>Kohno</surname><given-names>T.</given-names></name><name><surname>Ishii</surname><given-names>Y.</given-names></name><name><surname>Shimada</surname><given-names>Y.</given-names></name><name><surname>Shiraishi</surname><given-names>K.</given-names></name><name><surname>Iwakawa</surname><given-names>R.</given-names></name><etal/></person-group> (<year>2012</year>). <article-title>Identification of genes up-regulated in ALK-positive and EGFR/KRAS/ALK-negative lung adenocarcinomas.</article-title>
<source><italic>Cancer Res.</italic></source>
<volume>72</volume>
<fpage>100</fpage>–<lpage>111</lpage>. <pub-id pub-id-type="doi">10.1158/0008-5472.can-11-1403</pub-id><pub-id pub-id-type="pmid">22080568</pub-id></mixed-citation>
    </ref>
    <ref id="B33">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ramalingam</surname><given-names>S. S.</given-names></name><name><surname>Owonikoko</surname><given-names>T. K.</given-names></name><name><surname>Khuri</surname><given-names>F. R.</given-names></name></person-group> (<year>2011</year>). <article-title>Lung cancer: new biological insights and recent therapeutic advances.</article-title>
<source><italic>Cancer J. Clin.</italic></source>
<volume>61</volume>
<fpage>91</fpage>–<lpage>112</lpage>. <pub-id pub-id-type="doi">10.3322/caac.20102</pub-id></mixed-citation>
    </ref>
    <ref id="B34">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Raponi</surname><given-names>M.</given-names></name><name><surname>Zhang</surname><given-names>Y.</given-names></name><name><surname>Yu</surname><given-names>J.</given-names></name><name><surname>Chen</surname><given-names>G.</given-names></name><name><surname>Lee</surname><given-names>G.</given-names></name><name><surname>Taylor</surname><given-names>J. M.</given-names></name><etal/></person-group> (<year>2006</year>). <article-title>Gene expression signatures for predicting prognosis of squamous cell and adenocarcinomas of the lung.</article-title>
<source><italic>Cancer Res.</italic></source>
<volume>66</volume>
<fpage>7466</fpage>–<lpage>7472</lpage>. <pub-id pub-id-type="doi">10.1158/0008-5472.can-06-1191</pub-id><pub-id pub-id-type="pmid">16885343</pub-id></mixed-citation>
    </ref>
    <ref id="B35">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Robles</surname><given-names>A. I.</given-names></name><name><surname>Arai</surname><given-names>E.</given-names></name><name><surname>Mathé</surname><given-names>E. A.</given-names></name><name><surname>Okayama</surname><given-names>H.</given-names></name><name><surname>Schetter</surname><given-names>A. J.</given-names></name><name><surname>Brown</surname><given-names>D.</given-names></name><etal/></person-group> (<year>2015</year>). <article-title>An integrated prognostic classifier for stage I lung adenocarcinoma based on mRNA, microRNA, and DNA methylation biomarkers.</article-title>
<source><italic>J. Thora.c Oncol.</italic></source>
<volume>10</volume>
<fpage>1037</fpage>–<lpage>1048</lpage>. <pub-id pub-id-type="doi">10.1097/JTO.0000000000000560</pub-id></mixed-citation>
    </ref>
    <ref id="B36">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Roepman</surname><given-names>P.</given-names></name><name><surname>Jassem</surname><given-names>J.</given-names></name><name><surname>Smit</surname><given-names>E. F.</given-names></name><name><surname>Muley</surname><given-names>T.</given-names></name><name><surname>Niklinski</surname><given-names>J.</given-names></name><name><surname>van de Velde</surname><given-names>T.</given-names></name><etal/></person-group> (<year>2009</year>). <article-title>An Immune response enriched 72-gene prognostic profile for early-stage non–small-cell lung cancer.</article-title>
<source><italic>Clin. Cancer Res.</italic></source>
<volume>15</volume>
<fpage>284</fpage>–<lpage>290</lpage>. <pub-id pub-id-type="doi">10.1158/1078-0432.ccr-08-1258</pub-id><pub-id pub-id-type="pmid">19118056</pub-id></mixed-citation>
    </ref>
    <ref id="B37">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rousseaux</surname><given-names>S.</given-names></name><name><surname>Debernardi</surname><given-names>A.</given-names></name><name><surname>Jacquiau</surname><given-names>B.</given-names></name><name><surname>Vitte</surname><given-names>A.-L.</given-names></name><name><surname>Vesin</surname><given-names>A.</given-names></name><name><surname>Nagy-Mignotte</surname><given-names>H.</given-names></name><etal/></person-group> (<year>2013</year>). <article-title>Ectopic activation of germline and placental genes identifies aggressive metastasis-prone lung cancers.</article-title>
<source><italic>Sci. Transl. Med.</italic></source>
<volume>5</volume>:<issue>ra66</issue>
<pub-id pub-id-type="doi">10.1126/scitranslmed.3005723</pub-id></mixed-citation>
    </ref>
    <ref id="B38">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sato</surname><given-names>M.</given-names></name><name><surname>Larsen</surname><given-names>J. E.</given-names></name><name><surname>Lee</surname><given-names>W.</given-names></name><name><surname>Sun</surname><given-names>H.</given-names></name><name><surname>Shames</surname><given-names>D. S.</given-names></name><name><surname>Dalvi</surname><given-names>M. P.</given-names></name><etal/></person-group> (<year>2013</year>). <article-title>Human lung epithelial cells progressed to malignancy through specific oncogenic manipulations.</article-title>
<source><italic>Mol. Cancer Res.</italic></source>
<volume>11</volume>
<fpage>638</fpage>–<lpage>650</lpage>. <pub-id pub-id-type="doi">10.1158/1541-7786.MCR-12-0634-T</pub-id><pub-id pub-id-type="pmid">23449933</pub-id></mixed-citation>
    </ref>
    <ref id="B39">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shedden</surname><given-names>K.</given-names></name><name><surname>Taylor</surname><given-names>J. M. G.</given-names></name><name><surname>Enkemann</surname><given-names>S. A.</given-names></name><name><surname>Tsao</surname><given-names>M.-S.</given-names></name><name><surname>Yeatman</surname><given-names>T. J.</given-names></name><name><surname>Gerald</surname><given-names>W. L.</given-names></name><etal/></person-group> (<year>2008</year>). <article-title>Gene expression-based survival prediction in lung adenocarcinoma: a multi-site, blinded validation study.</article-title>
<source><italic>Nat. Med.</italic></source>
<volume>14</volume>
<fpage>822</fpage>–<lpage>827</lpage>. <pub-id pub-id-type="doi">10.1038/nm.1790</pub-id><pub-id pub-id-type="pmid">18641660</pub-id></mixed-citation>
    </ref>
    <ref id="B40">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Staaf</surname><given-names>J.</given-names></name><name><surname>Isaksson</surname><given-names>S.</given-names></name><name><surname>Karlsson</surname><given-names>A.</given-names></name><name><surname>Jonsson</surname><given-names>M.</given-names></name><name><surname>Johansson</surname><given-names>L.</given-names></name><name><surname>Jonsson</surname><given-names>P.</given-names></name><etal/></person-group> (<year>2013</year>). <article-title>Landscape of somatic allelic imbalances and copy number alterations in human lung carcinoma.</article-title>
<source><italic>Int. J. Cancer</italic></source>
<volume>132</volume>
<fpage>2020</fpage>–<lpage>2031</lpage>. <pub-id pub-id-type="doi">10.1002/ijc.27879</pub-id><pub-id pub-id-type="pmid">23023297</pub-id></mixed-citation>
    </ref>
    <ref id="B41">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Staaf</surname><given-names>J.</given-names></name><name><surname>Jönsson</surname><given-names>G.</given-names></name><name><surname>Jönsson</surname><given-names>M.</given-names></name><name><surname>Karlsson</surname><given-names>A.</given-names></name><name><surname>Isaksson</surname><given-names>S.</given-names></name><name><surname>Salomonsson</surname><given-names>A.</given-names></name><etal/></person-group> (<year>2012</year>). <article-title>Relation between smoking history and gene expression profiles in lung adenocarcinomas.</article-title>
<source><italic>BMC Med. Genomics</italic></source>
<volume>5</volume>:<issue>22</issue>
<pub-id pub-id-type="doi">10.1186/1755-8794-5-22</pub-id></mixed-citation>
    </ref>
    <ref id="B42">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Takeuchi</surname><given-names>T.</given-names></name><name><surname>Tomida</surname><given-names>S.</given-names></name><name><surname>Yatabe</surname><given-names>Y.</given-names></name><name><surname>Kosaka</surname><given-names>T.</given-names></name><name><surname>Osada</surname><given-names>H.</given-names></name><name><surname>Yanagisawa</surname><given-names>K.</given-names></name><etal/></person-group> (<year>2006</year>). <article-title>Expression profile–defined classification of lung adenocarcinoma shows close relationship with underlying major genetic changes and clinicopathologic behaviors.</article-title>
<source><italic>J. Clin. Oncol.</italic></source>
<volume>24</volume>
<fpage>1679</fpage>–<lpage>1688</lpage>. <pub-id pub-id-type="doi">10.1200/JCO.2005.03.8224</pub-id><pub-id pub-id-type="pmid">16549822</pub-id></mixed-citation>
    </ref>
    <ref id="B43">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tang</surname><given-names>Z.</given-names></name><name><surname>Li</surname><given-names>C.</given-names></name><name><surname>Kang</surname><given-names>B.</given-names></name><name><surname>Gao</surname><given-names>G.</given-names></name><name><surname>Li</surname><given-names>C.</given-names></name><name><surname>Zhang</surname><given-names>Z.</given-names></name></person-group> (<year>2017</year>). <article-title>GEPIA: a web server for cancer and normal gene expression profiling and interactive analyses.</article-title>
<source><italic>Nucleic Acids Res.</italic></source>
<volume>45</volume>
<fpage>W98</fpage>–<lpage>W102</lpage>. <pub-id pub-id-type="doi">10.1093/nar/gkx247</pub-id><pub-id pub-id-type="pmid">28407145</pub-id></mixed-citation>
    </ref>
    <ref id="B44">
      <mixed-citation publication-type="journal"><collab>The Cancer Genome Atlas Research Network</collab> (<year>2012</year>). <article-title>Comprehensive genomic characterization of squamous cell lung cancers.</article-title>
<source><italic>Nature</italic></source>
<volume>489</volume>
<fpage>519</fpage>–<lpage> 525</lpage>.<pub-id pub-id-type="pmid">22960745</pub-id></mixed-citation>
    </ref>
    <ref id="B45">
      <mixed-citation publication-type="journal"><collab>The Cancer Genome Atlas Research Network</collab> (<year>2014</year>). <article-title>Comprehensive molecular profiling of lung adenocarcinoma.</article-title>
<source><italic>Nature</italic></source>
<volume>511</volume>
<fpage>543</fpage>–<lpage>550</lpage>. <pub-id pub-id-type="doi">10.1038/s41586-018-0228-6</pub-id><pub-id pub-id-type="pmid">25079552</pub-id></mixed-citation>
    </ref>
    <ref id="B46">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tomida</surname><given-names>S.</given-names></name><name><surname>Koshikawa</surname><given-names>K.</given-names></name><name><surname>Yatabe</surname><given-names>Y.</given-names></name><name><surname>Harano</surname><given-names>T.</given-names></name><name><surname>Ogura</surname><given-names>N.</given-names></name><name><surname>Mitsudomi</surname><given-names>T.</given-names></name><etal/></person-group> (<year>2004</year>). <article-title>Gene expression-based, individualized outcome prediction for surgically treated lung cancer patients.</article-title>
<source><italic>Oncogene</italic></source>
<volume>23</volume>
<fpage>5360</fpage>–<lpage>5370</lpage>. <pub-id pub-id-type="doi">10.1038/sj.onc.1207697</pub-id><pub-id pub-id-type="pmid">15064725</pub-id></mixed-citation>
    </ref>
    <ref id="B47">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tomida</surname><given-names>S.</given-names></name><name><surname>Takeuchi</surname><given-names>T.</given-names></name><name><surname>Shimada</surname><given-names>Y.</given-names></name><name><surname>Arima</surname><given-names>C.</given-names></name><name><surname>Matsuo</surname><given-names>K.</given-names></name><name><surname>Mitsudomi</surname><given-names>T.</given-names></name><etal/></person-group> (<year>2009</year>). <article-title>Relapse-related molecular signature in lung adenocarcinomas identifies patients with dismal prognosis.</article-title>
<source><italic>J. Clin. Oncol.</italic></source>
<volume>27</volume>
<fpage>2793</fpage>–<lpage>2799</lpage>. <pub-id pub-id-type="doi">10.1200/JCO.2008.19.7053</pub-id><pub-id pub-id-type="pmid">19414676</pub-id></mixed-citation>
    </ref>
    <ref id="B48">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>F.</given-names></name><name><surname>Wang</surname><given-names>Q.</given-names></name><name><surname>Li</surname><given-names>N.</given-names></name><name><surname>Ge</surname><given-names>L.</given-names></name><name><surname>Yang</surname><given-names>M.</given-names></name><name><surname>An</surname><given-names>Y.</given-names></name><etal/></person-group> (<year>2019a</year>). <article-title>OSuvm: an interactive online consensus survival tool for uveal melanoma prognosis analysis.</article-title>
<source><italic>Mol. Carcinog.</italic></source>
<volume>59</volume>
<fpage>56</fpage>–<lpage>61</lpage>. <pub-id pub-id-type="doi">10.1002/mc.23128</pub-id><pub-id pub-id-type="pmid">31646691</pub-id></mixed-citation>
    </ref>
    <ref id="B49">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>F.</given-names></name><name><surname>Wang</surname><given-names>Q.</given-names></name><name><surname>Li</surname><given-names>N.</given-names></name><name><surname>Ge</surname><given-names>L.</given-names></name><name><surname>Yang</surname><given-names>M.</given-names></name><name><surname>An</surname><given-names>Y.</given-names></name><etal/></person-group> (<year>2020</year>). <article-title>OSuvm: an interactive online consensus survival tool for uveal melanoma prognosis analysis.</article-title>
<source><italic>Mol. Carcinog.</italic></source>
<volume>59</volume>
<fpage>56</fpage>–<lpage>61</lpage>. <?supplied-pmid 31646691?><pub-id pub-id-type="pmid">31646691</pub-id></mixed-citation>
    </ref>
    <ref id="B50">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>Q.</given-names></name><name><surname>Xie</surname><given-names>L.</given-names></name><name><surname>Dang</surname><given-names>Y.</given-names></name><name><surname>Sun</surname><given-names>X.</given-names></name><name><surname>Xie</surname><given-names>T.</given-names></name><name><surname>Guo</surname><given-names>J.</given-names></name><etal/></person-group> (<year>2019b</year>). <article-title>OSlms: a web server to evaluate the prognostic value of genes in leiomyosarcoma.</article-title>
<source><italic>Front. Oncol.</italic></source>
<volume>9</volume>:<issue>190</issue>
<pub-id pub-id-type="doi">10.3389/fonc.2019.00190</pub-id></mixed-citation>
    </ref>
    <ref id="B51">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>Q.</given-names></name><name><surname>Zhang</surname><given-names>L.</given-names></name><name><surname>Yan</surname><given-names>Z.</given-names></name><name><surname>Xie</surname><given-names>L.</given-names></name></person-group> (<year>2019c</year>). <article-title>OScc: an online survival analysis web server to evaluate the prognostic value of biomarkers in cervical cancer.</article-title>
<source><italic>Future Oncol.</italic></source>
<volume>15</volume>
<fpage>3693</fpage>–<lpage>3699</lpage>. <pub-id pub-id-type="doi">10.2217/fon-2019-0412</pub-id><pub-id pub-id-type="pmid">31512935</pub-id></mixed-citation>
    </ref>
    <ref id="B52">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wilkerson</surname><given-names>M. D.</given-names></name><name><surname>Yin</surname><given-names>X.</given-names></name><name><surname>Hoadley</surname><given-names>K. A.</given-names></name><name><surname>Liu</surname><given-names>Y.</given-names></name><name><surname>Hayward</surname><given-names>M. C.</given-names></name><name><surname>Cabanski</surname><given-names>C. R.</given-names></name><etal/></person-group> (<year>2010</year>). <article-title>Lung squamous cell carcinoma mRNA expression subtypes are reproducible, clinically important, and correspond to normal cell types.</article-title>
<source><italic>Clin. Cancer Res.</italic></source>
<volume>16</volume>
<fpage>4864</fpage>–<lpage>4875</lpage>. <pub-id pub-id-type="doi">10.1158/1078-0432.CCR-10-0199</pub-id><pub-id pub-id-type="pmid">20643781</pub-id></mixed-citation>
    </ref>
    <ref id="B53">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wilkerson</surname><given-names>M. D.</given-names></name><name><surname>Yin</surname><given-names>X.</given-names></name><name><surname>Walter</surname><given-names>V.</given-names></name><name><surname>Zhao</surname><given-names>N.</given-names></name><name><surname>Cabanski</surname><given-names>C. R.</given-names></name><name><surname>Hayward</surname><given-names>M. C.</given-names></name><etal/></person-group> (<year>2012</year>). <article-title>Differential pathogenesis of lung adenocarcinoma subtypes involving sequence mutations, copy number, chromosomal instability, and methylation.</article-title>
<source><italic>PloS One</italic></source>
<volume>7</volume>:<issue>e36530</issue>
<pub-id pub-id-type="doi">10.1371/journal.pone.0036530</pub-id></mixed-citation>
    </ref>
    <ref id="B54">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Xie</surname><given-names>L.</given-names></name><name><surname>Dang</surname><given-names>Y.</given-names></name><name><surname>Guo</surname><given-names>J.</given-names></name><name><surname>Sun</surname><given-names>X.</given-names></name><name><surname>Xie</surname><given-names>T.</given-names></name><name><surname>Zhang</surname><given-names>L.</given-names></name><etal/></person-group> (<year>2019a</year>). <article-title>High KRT8 expression independently predicts poor prognosis for lung adenocarcinoma patients.</article-title>
<source><italic>Genes</italic></source>
<volume>10</volume>:<issue>36</issue>. <pub-id pub-id-type="doi">10.3390/genes10010036</pub-id>
<?supplied-pmid 30634629?><pub-id pub-id-type="pmid">30634629</pub-id></mixed-citation>
    </ref>
    <ref id="B55">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Xie</surname><given-names>L.</given-names></name><name><surname>Wang</surname><given-names>Q.</given-names></name><name><surname>Dang</surname><given-names>Y.</given-names></name><name><surname>Ge</surname><given-names>L.</given-names></name><name><surname>Sun</surname><given-names>X.</given-names></name><name><surname>Li</surname><given-names>N.</given-names></name><etal/></person-group> (<year>2019b</year>). <article-title>OSkirc: a web tool for identifying prognostic biomarkers in kidney renal clear cell carcinoma.</article-title>
<source><italic>Future Oncol.</italic></source>
<volume>15</volume>
<fpage>3103</fpage>–<lpage>3110</lpage>. <pub-id pub-id-type="doi">10.3892/ol.2019.10440</pub-id><pub-id pub-id-type="pmid">31368353</pub-id></mixed-citation>
    </ref>
    <ref id="B56">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Xie</surname><given-names>L.</given-names></name><name><surname>Wang</surname><given-names>Q.</given-names></name><name><surname>Nan</surname><given-names>F.</given-names></name><name><surname>Ge</surname><given-names>L.</given-names></name><name><surname>Dang</surname><given-names>Y.</given-names></name></person-group> (<year>2019c</year>). <article-title>OSacc: gene expression-based survival analysis web tool for adrenocortical carcinoma.</article-title>
<source><italic>Cancer Manag Res.</italic></source>
<volume>11</volume>
<fpage>9145</fpage>–<lpage>9152</lpage>. <pub-id pub-id-type="doi">10.2147/cmar.s215586</pub-id><pub-id pub-id-type="pmid">31749633</pub-id></mixed-citation>
    </ref>
    <ref id="B57">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Xie</surname><given-names>Y.</given-names></name><name><surname>Xiao</surname><given-names>G.</given-names></name><name><surname>Coombes</surname><given-names>K. R.</given-names></name><name><surname>Behrens</surname><given-names>C.</given-names></name><name><surname>Solis</surname><given-names>L. M.</given-names></name><name><surname>Raso</surname><given-names>G.</given-names></name><etal/></person-group> (<year>2011</year>). <article-title>Robust gene expression signature from formalin-fixed paraffin-embedded samples predicts prognosis of non-small-cell lung cancer patients.</article-title>
<source><italic>Clin. Cancer Res.</italic></source>
<volume>17</volume>
<fpage>5705</fpage>–<lpage>5714</lpage>. <pub-id pub-id-type="doi">10.1158/1078-0432.CCR-11-0196</pub-id><pub-id pub-id-type="pmid">21742808</pub-id></mixed-citation>
    </ref>
    <ref id="B58">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yan</surname><given-names>Z.</given-names></name><name><surname>Wang</surname><given-names>Q.</given-names></name><name><surname>Sun</surname><given-names>X.</given-names></name><name><surname>Ban</surname><given-names>B.</given-names></name><name><surname>Lu</surname><given-names>Z.</given-names></name><name><surname>Dang</surname><given-names>Y.</given-names></name><etal/></person-group> (<year>2019</year>). <article-title>OSbrca: a web server for breast cancer prognostic biomarker investigation with massive data from tens of cohorts.</article-title>
<source><italic>Front. Oncol.</italic></source>
<volume>9</volume>:<issue>1349</issue>. <pub-id pub-id-type="doi">10.3389/fonc.2019.01349</pub-id>
<?supplied-pmid 31921624?><pub-id pub-id-type="pmid">31921624</pub-id></mixed-citation>
    </ref>
    <ref id="B59">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname><given-names>G.</given-names></name><name><surname>Wang</surname><given-names>Q.</given-names></name><name><surname>Yang</surname><given-names>M.</given-names></name><name><surname>Yao</surname><given-names>X.</given-names></name><name><surname>Qi</surname><given-names>X.</given-names></name><name><surname>An</surname><given-names>Y.</given-names></name><etal/></person-group> (<year>2020</year>). <article-title>OSpaad: an online tool to perform survival analysis by integrating gene expression profiling and long-term follow-up data of 1319 pancreatic carcinoma patients.</article-title>
<source><italic>Mol. Carcinog.</italic></source>
<volume>59</volume>
<fpage>304</fpage>–<lpage>310</lpage>. <pub-id pub-id-type="doi">10.1002/mc.23154</pub-id>
<?supplied-pmid 31912599?><pub-id pub-id-type="pmid">31912599</pub-id></mixed-citation>
    </ref>
    <ref id="B60">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname><given-names>G.</given-names></name><name><surname>Wang</surname><given-names>Q.</given-names></name><name><surname>Yang</surname><given-names>M.</given-names></name><name><surname>Yuan</surname><given-names>Q.</given-names></name><name><surname>Dang</surname><given-names>Y.</given-names></name><name><surname>Sun</surname><given-names>X.</given-names></name><etal/></person-group> (<year>2019</year>). <article-title>OSblca: a web server for investigating prognostic biomarkers of bladder cancer patients.</article-title>
<source><italic>Front. Oncol.</italic></source>
<volume>9</volume>:<issue>466</issue>. <pub-id pub-id-type="doi">10.2217/fon-2019-0296</pub-id>
<?supplied-pmid 31275847?><pub-id pub-id-type="pmid">31275847</pub-id></mixed-citation>
    </ref>
    <ref id="B61">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zheng</surname><given-names>H.</given-names></name><name><surname>Zhang</surname><given-names>G.</given-names></name><name><surname>Zhang</surname><given-names>L.</given-names></name><name><surname>Wang</surname><given-names>Q.</given-names></name><name><surname>Li</surname><given-names>H.</given-names></name><name><surname>Han</surname><given-names>Y.</given-names></name><etal/></person-group> (<year>2020</year>). <article-title>Comprehensive review of web servers and bioinformatics tools for cancer prognosis analysis.</article-title>
<source><italic>Front. Oncol.</italic></source>
<volume>10</volume>:<issue>68</issue>
<pub-id pub-id-type="doi">10.3389/fonc.2020.00068</pub-id></mixed-citation>
    </ref>
    <ref id="B62">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhu</surname><given-names>C.-Q.</given-names></name><name><surname>Ding</surname><given-names>K.</given-names></name><name><surname>Strumpf</surname><given-names>D.</given-names></name><name><surname>Weir</surname><given-names>B. A.</given-names></name><name><surname>Meyerson</surname><given-names>M.</given-names></name><name><surname>Pennell</surname><given-names>N.</given-names></name><etal/></person-group> (<year>2010</year>). <article-title>Prognostic and predictive gene signature for adjuvant chemotherapy in resected non-small-cell lung cancer.</article-title>
<source><italic>J.Clin. Oncol.</italic></source>
<volume>28</volume>
<fpage>4417</fpage>–<lpage>4424</lpage>. <pub-id pub-id-type="doi">10.1200/JCO.2009.26.4325</pub-id><pub-id pub-id-type="pmid">20823422</pub-id></mixed-citation>
    </ref>
  </ref-list>
</back>
